{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T18:25:11Z","timestamp":1794939911641,"version":"4.9.1"},"reference-count":302,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"DOI":"10.1038\/s41392-026-03001-y","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T09:11:11Z","timestamp":1788858671000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Disulfidptosis: molecular mechanisms and therapeutic targets"],"prefix":"10.1038","volume":"11","author":[{"given":"Cong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binghui","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6654-2270","authenticated-orcid":false,"given":"Xiaofeng","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2446-1122","authenticated-orcid":false,"given":"Zhe","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"key":"3001_CR1","doi-asserted-by":"publisher","first-page":"1291385","DOI":"10.3389\/fimmu.2023.1291385","volume":"14","author":"Y Guo","year":"2023","unstructured":"Guo, Y. et al. Construction and experimental validation of a signature for predicting prognosis and immune infiltration analysis of glioma based on disulfidptosis-related lncRNAs. Front. Immunol. 14, 1291385 (2023).","journal-title":"Front. Immunol."},{"key":"3001_CR2","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.trecan.2023.02.001","volume":"9","author":"K H\u00e4nggi","year":"2023","unstructured":"H\u00e4nggi, K. & Ruffell, B. Cell death, therapeutics, and the immune response in cancer. Trends Cancer 9, 381\u2013396 (2023).","journal-title":"Trends Cancer"},{"key":"3001_CR3","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/s41423-020-00630-3","volume":"18","author":"D Bertheloot","year":"2021","unstructured":"Bertheloot, D., Latz, E. & Franklin, B. S. Necroptosis, pyroptosis and apoptosis: an intricate game of cell death. Cell. Mol. Immunol. 18, 1106\u20131121 (2021).","journal-title":"Cell. Mol. Immunol."},{"key":"3001_CR4","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41556-023-01091-2","volume":"25","author":"X Liu","year":"2023","unstructured":"Liu, X. et al. Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis. Nat. Cell Biol. 25, 404\u2013414 (2023).","journal-title":"Nat. Cell Biol."},{"key":"3001_CR5","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","volume":"12","author":"P Koppula","year":"2021","unstructured":"Koppula, P., Zhuang, L. & Gan, B. Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell 12, 599\u2013620 (2021).","journal-title":"Protein Cell"},{"key":"3001_CR6","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/s41556-020-0496-x","volume":"22","author":"X Liu","year":"2020","unstructured":"Liu, X. et al. Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer. Nat. Cell Biol. 22, 476\u2013486 (2020).","journal-title":"Nat. Cell Biol."},{"key":"3001_CR7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13046-023-02675-4","volume":"42","author":"P Zheng","year":"2023","unstructured":"Zheng, P., Zhou, C., Ding, Y. & Duan, S. Disulfidptosis: a new target for metabolic cancer therapy. J. Exp. Clin. Cancer Res. 42, 103 (2023).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"3001_CR8","doi-asserted-by":"publisher","first-page":"1294459","DOI":"10.3389\/fimmu.2023.1294459","volume":"14","author":"Y Zhou","year":"2023","unstructured":"Zhou, Y. et al. Leveraging a gene signature associated with disulfidptosis identified by machine learning to forecast clinical outcomes, immunological heterogeneities, and potential therapeutic targets within lower-grade glioma. Front. Immunol. 14, 1294459 (2023).","journal-title":"Front. Immunol."},{"key":"3001_CR9","doi-asserted-by":"publisher","first-page":"R241","DOI":"10.1016\/j.cub.2025.02.042","volume":"35","author":"Q Li","year":"2025","unstructured":"Li, Q., Zhuang, L. & Gan, B. Disulfidptosis. Curr. Biol. 35, R241\u2013R243 (2025).","journal-title":"Curr. Biol."},{"key":"3001_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202408556","volume":"12","author":"Z Song","year":"2025","unstructured":"Song, Z. et al. Glucose deprivation-induced disulfidptosis via the SLC7A11-INF2 axis: pan-cancer prognostic exploration and therapeutic validation. Adv. Sci. 12, e08556 (2025).","journal-title":"Adv. Sci."},{"key":"3001_CR11","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.tcb.2023.07.009","volume":"34","author":"X Liu","year":"2024","unstructured":"Liu, X., Zhuang, L. & Gan, B. Disulfidptosis: disulfide stress-induced cell death. Trends Cell Biol. 34, 327\u2013337 (2024).","journal-title":"Trends Cell Biol."},{"key":"3001_CR12","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.bbrc.2008.03.134","volume":"370","author":"HX Qiao","year":"2008","unstructured":"Qiao, H. X. et al. JNK activation mediates the apoptosis of xCT-deficient cells. Biochem. Biophys. Res. Commun. 370, 584\u2013588 (2008).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"3001_CR13","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.febslet.2011.04.018","volume":"585","author":"XX Liu","year":"2011","unstructured":"Liu, X. X. et al. MicroRNA-26b is underexpressed in human breast cancer and induces cell apoptosis by targeting SLC7A11. FEBS Lett. 585, 1363\u20131367 (2011).","journal-title":"FEBS Lett."},{"key":"3001_CR14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1756-8722-7-30","volume":"7","author":"L Dai","year":"2014","unstructured":"Dai, L., Cao, Y., Chen, Y., Parsons, C. & Qin, Z. Targeting xCT, a cystine-glutamate transporter induces apoptosis and tumor regression for KSHV\/HIV-associated lymphoma. J. Hematol. Oncol. 7, 30 (2014).","journal-title":"J. Hematol. Oncol."},{"key":"3001_CR15","doi-asserted-by":"publisher","first-page":"3558","DOI":"10.7150\/ijbs.85454","volume":"19","author":"X Wang","year":"2023","unstructured":"Wang, X., Kong, X., Feng, X. & Jiang, D. S. Effects of DNA, RNA, and protein methylation on the regulation of ferroptosis. Int. J. Biol. Sci. 19, 3558\u20133575 (2023).","journal-title":"Int. J. Biol. Sci."},{"key":"3001_CR16","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang, X., Stockwell, B. R. & Conrad, M. Ferroptosis: mechanisms, biology and role in disease. Nat. Rev. Mol. Cell Biol. 22, 266\u2013282 (2021).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"3001_CR17","doi-asserted-by":"publisher","first-page":"116040","DOI":"10.1016\/j.ejmech.2023.116040","volume":"265","author":"R Li","year":"2024","unstructured":"Li, R. et al. Targeted regulated cell death with small molecule compounds in colorectal cancer: current perspectives of targeted therapy and molecular mechanisms. Eur. J. Med. Chem. 265, 116040 (2024).","journal-title":"Eur. J. Med. Chem."},{"key":"3001_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27414-1","volume":"12","author":"JL Parker","year":"2021","unstructured":"Parker, J. L. et al. Molecular basis for redox control by the human cystine\/glutamate antiporter system xc(). Nat. Commun. 12, 7147 (2021).","journal-title":"Nat. Commun."},{"key":"3001_CR19","doi-asserted-by":"publisher","first-page":"910292","DOI":"10.3389\/fphar.2022.910292","volume":"13","author":"FJ Li","year":"2022","unstructured":"Li, F. J. et al. System X(c) (-)\/GSH\/GPX4 axis: an important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy. Front. Pharmacol. 13, 910292 (2022).","journal-title":"Front. Pharmacol."},{"key":"3001_CR20","doi-asserted-by":"publisher","first-page":"10065","DOI":"10.1039\/C9SC02618E","volume":"10","author":"J Liu","year":"2019","unstructured":"Liu, J. et al. Exploring cysteine regulation in cancer cell survival with a highly specific \u201cLock and Key\u201d fluorescent probe for cysteine. Chem. Sci. 10, 10065\u201310071 (2019).","journal-title":"Chem. Sci."},{"key":"3001_CR21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1089\/ars.2017.7115","volume":"29","author":"M Maiorino","year":"2018","unstructured":"Maiorino, M., Conrad, M. & Ursini, F. GPx4, lipid peroxidation, and cell death: discoveries, rediscoveries, and open issues. Antioxid. Redox Signal 29, 61\u201374 (2018).","journal-title":"Antioxid. Redox Signal"},{"key":"3001_CR22","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang, W. S. et al. Regulation of ferroptotic cancer cell death by GPX4. Cell 156, 317\u2013331 (2014).","journal-title":"Cell"},{"key":"3001_CR23","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1080\/15548627.2020.1810918","volume":"17","author":"X Chen","year":"2021","unstructured":"Chen, X., Li, J., Kang, R., Klionsky, D. J. & Tang, D. Ferroptosis: machinery and regulation. Autophagy 17, 2054\u20132081 (2021).","journal-title":"Autophagy"},{"key":"3001_CR24","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/0378-4274(95)03532-X","volume":"82-83","author":"CC Winterbourn","year":"1995","unstructured":"Winterbourn, C. C. Toxicity of iron and hydrogen peroxide: the Fenton reaction. Toxicol. Lett. 82-83, 969\u2013974 (1995).","journal-title":"Toxicol. Lett."},{"key":"3001_CR25","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1021\/acsnano.4c15932","volume":"19","author":"Q Li","year":"2025","unstructured":"Li, Q. et al. Enhancing ferroptosis-mediated radiosensitization via synergistic disulfidptosis induction. ACS Nano 19, 1757\u20131770 (2025).","journal-title":"ACS Nano"},{"key":"3001_CR26","doi-asserted-by":"publisher","first-page":"14233","DOI":"10.1021\/acsnano.5c00730","volume":"19","author":"M Zhang","year":"2025","unstructured":"Zhang, M. et al. Synchronously evoking disulfidptosis and ferroptosis via systematical glucose deprivation targeting SLC7A11\/GSH\/GPX4 antioxidant axis. ACS Nano 19, 14233\u201314248 (2025).","journal-title":"ACS Nano"},{"key":"3001_CR27","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3390\/ijms25010342","volume":"25","author":"DO Moon","year":"2024","unstructured":"Moon, D. O. NADPH dynamics: linking insulin resistance and \u03b2-cells ferroptosis in diabetes mellitus. Int. J. Mol. Sci. 25, 342 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"3001_CR28","doi-asserted-by":"publisher","first-page":"188955","DOI":"10.1016\/j.bbcan.2023.188955","volume":"1878","author":"X Wang","year":"2023","unstructured":"Wang, X., Lin, J., Li, Z. & Wang, M. In what area of biology has a \u201cnew\u201d type of cell death been discovered? Biochim. Biophys. Acta Rev. Cancer 1878, 188955 (2023).","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"3001_CR29","doi-asserted-by":"publisher","first-page":"496","DOI":"10.21037\/tcr-23-1594","volume":"13","author":"JF Liu","year":"2024","unstructured":"Liu, J. F. et al. Disulfidptosis and ferroptosis related genes predict prognosis and personalize treatment for hepatocellular carcinoma. Transl. Cancer Res. 13, 496\u2013514 (2024).","journal-title":"Transl. Cancer Res."},{"key":"3001_CR30","doi-asserted-by":"publisher","first-page":"1207068","DOI":"10.3389\/fonc.2023.1207068","volume":"13","author":"D Zhang","year":"2023","unstructured":"Zhang, D. et al. An integrative multi-omics analysis based on disulfidptosis-related prognostic signature and distinct subtypes of clear cell renal cell carcinoma. Front. Oncol. 13, 1207068 (2023).","journal-title":"Front. Oncol."},{"key":"3001_CR31","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s00432-024-05630-8","volume":"150","author":"Z Mengzhen","year":"2024","unstructured":"Mengzhen, Z. et al. Integrated machine learning-driven disulfidptosis profiling: CYFIP1 and EMILIN1 as therapeutic nodes in neuroblastoma. J. Cancer Res. Clin. Oncol. 150, 109 (2024).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"3001_CR32","first-page":"744","volume":"54","author":"M Zhang","year":"2025","unstructured":"Zhang, M. et al. Regulating SLC7A11\/GSH\/GPX4 axis by glucose dyshomeostasis to simultaneously promote disulfidptosis, cuproptosis and ferroptosis. Bioact. Mater. 54, 744\u2013758 (2025).","journal-title":"Bioact. Mater."},{"key":"3001_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-024-01454-3","volume":"24","author":"C Tang","year":"2024","unstructured":"Tang, C., Fan, Y. & Zhu, S. Preliminary findings on the development of a predictive model for BLCA based on disulfidptosis-associated IncRNAs signature. BMC Urol. 24, 69 (2024).","journal-title":"BMC Urol."},{"key":"3001_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-026-08462-1","volume":"17","author":"R Zhuang","year":"2026","unstructured":"Zhuang, R. et al. PDHA1-acetylation signaling suppresses cuproptosis to attenuate anti-androgen effect in prostate cancer. Cell Death Dis. 17, 243 (2026).","journal-title":"Cell Death Dis."},{"key":"3001_CR35","doi-asserted-by":"publisher","first-page":"1287808","DOI":"10.3389\/fonc.2023.1287808","volume":"13","author":"C Dong","year":"2023","unstructured":"Dong, C., Guo, Y., Wang, P., Yin, S. & Ge, X. Comprehensive analysis of disulfidptosis-related lncRNA features for prognosis and immune landscape prediction in colorectal cancer. Front. Oncol. 13, 1287808 (2023).","journal-title":"Front. Oncol."},{"key":"3001_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-025-03722-2","volume":"23","author":"X Liang","year":"2025","unstructured":"Liang, X. et al. Cascade-targeting copper homeostasis nano-regulators for mild-photothermal boosted cuproptosis\/ferroptosis mediated breast cancer therapy. J. Nanobiotechnol. 23, 651 (2025).","journal-title":"J. Nanobiotechnol."},{"key":"3001_CR37","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s00432-024-05691-9","volume":"150","author":"H Xue","year":"2024","unstructured":"Xue, H., Sun, Q., Zhang, H., Huang, H. & Xue, H. Disulfidptosis features and prognosis in head and neck squamous cell carcinoma patients: unveiling and validating the prognostic signature across cohorts. J. Cancer Res. Clin. Oncol. 150, 156 (2024).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"3001_CR38","doi-asserted-by":"publisher","first-page":"1204335","DOI":"10.3389\/fonc.2023.1204335","volume":"13","author":"X Chen","year":"2023","unstructured":"Chen, X., Wang, Z., Wu, Y., Lan, Y. & Li, Y. Typing and modeling of hepatocellular carcinoma based on disulfidptosis-related amino acid metabolism genes for predicting prognosis and guiding individualized treatment. Front. Oncol. 13, 1204335 (2023).","journal-title":"Front. Oncol."},{"key":"3001_CR39","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1186\/s12876-025-04174-6","volume":"25","author":"Q Ji","year":"2025","unstructured":"Ji, Q., Shi, C., Gu, X., Yang, L. & Sun, Y. Elucidating the role of AC026412.3 in hepatocellular carcinoma: a prognostic disulfidptosis-related LncRNAs model perspective. BMC Gastroenterol. 25, 579 (2025).","journal-title":"BMC Gastroenterol."},{"key":"3001_CR40","doi-asserted-by":"publisher","first-page":"1362543","DOI":"10.3389\/fimmu.2024.1362543","volume":"15","author":"X Yang","year":"2024","unstructured":"Yang, X. et al. Integrated multiomic analysis reveals disulfidptosis subtypes in glioblastoma: implications for immunotherapy, targeted therapy, and chemotherapy. Front. Immunol. 15, 1362543 (2024).","journal-title":"Front. Immunol."},{"key":"3001_CR41","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3390\/biom14030266","volume":"14","author":"XY Sun","year":"2024","unstructured":"Sun, X. Y. et al. ALMS1-IT1: a key player in the novel disulfidptosis-related LncRNA prognostic signature for head and neck squamous cell carcinoma. Biomolecules 14, 266 (2024).","journal-title":"Biomolecules"},{"key":"3001_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-025-02447-x","volume":"23","author":"H Qiu","year":"2025","unstructured":"Qiu, H. et al. SLC7A11 as a bridge between ferroptosis and disulfidptosis: a promising target for tumor treatment. Cell Commun. Signal 23, 460 (2025).","journal-title":"Cell Commun. Signal"},{"key":"3001_CR43","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.1016\/j.asjsur.2024.02.041","volume":"47","author":"D Li","year":"2024","unstructured":"Li, D., Li, X., Lv, J. & Li, S. Creation of signatures and identification of molecular subtypes based on disulfidptosis-related genes for glioblastoma patients\u2019 prognosis and immunological activity. Asian J. Surg. 47, 3464\u20133477 (2024).","journal-title":"Asian J. Surg."},{"key":"3001_CR44","doi-asserted-by":"publisher","first-page":"20240906","DOI":"10.1515\/med-2024-0906","volume":"19","author":"Y Li","year":"2024","unstructured":"Li, Y. et al. Comprehensive analysis based on the disulfidptosis-related genes identifies hub genes and immune infiltration for pancreatic adenocarcinoma. Open Med. 19, 20240906 (2024).","journal-title":"Open Med."},{"key":"3001_CR45","doi-asserted-by":"publisher","first-page":"9091","DOI":"10.7150\/thno.115661","volume":"15","author":"R Liu","year":"2025","unstructured":"Liu, R. et al. The contrasting regulatory effects of valproic acid on ferroptosis and disulfidptosis in hepatocellular carcinoma. Theranostics 15, 9091\u20139113 (2025).","journal-title":"Theranostics"},{"key":"3001_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02445-0","volume":"24","author":"Z Jing","year":"2025","unstructured":"Jing, Z. et al. Advances in novel cell death mechanisms in breast cancer: intersecting perspectives on ferroptosis, cuproptosis, disulfidptosis, and pyroptosis. Mol. Cancer 24, 224 (2025).","journal-title":"Mol. Cancer"},{"key":"3001_CR47","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1756-9966-30-87","volume":"30","author":"RS Wong","year":"2011","unstructured":"Wong, R. S. Apoptosis in cancer: from pathogenesis to treatment. J. Exp. Clin. Cancer Res. 30, 87 (2011).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"3001_CR48","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/s41580-023-00629-4","volume":"24","author":"PE Czabotar","year":"2023","unstructured":"Czabotar, P. E. & Garcia-Saez, A. J. Mechanisms of BCL-2 family proteins in mitochondrial apoptosis. Nat. Rev. Mol. Cell Biol. 24, 732\u2013748 (2023).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"3001_CR49","doi-asserted-by":"publisher","first-page":"7925","DOI":"10.1074\/jbc.M307807200","volume":"279","author":"T Vanden Berghe","year":"2004","unstructured":"Vanden Berghe, T. et al. Differential signaling to apoptotic and necrotic cell death by Fas-associated death domain protein FADD. J. Biol. Chem. 279, 7925\u20137933 (2004).","journal-title":"J. Biol. Chem."},{"key":"3001_CR50","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0092-8674(03)00521-X","volume":"114","author":"O Micheau","year":"2003","unstructured":"Micheau, O. & Tschopp, J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114, 181\u2013190 (2003).","journal-title":"Cell"},{"key":"3001_CR51","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/S1097-2765(01)00320-3","volume":"8","author":"EH Cheng","year":"2001","unstructured":"Cheng, E. H. et al. BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol. Cell. 8, 705\u2013711 (2001).","journal-title":"Mol. Cell."},{"key":"3001_CR52","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1101\/gad.1093903","volume":"17","author":"D Nijhawan","year":"2003","unstructured":"Nijhawan, D. et al. Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation. Genes Dev. 17, 1475\u20131486 (2003).","journal-title":"Genes Dev."},{"key":"3001_CR53","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1093\/emboj\/17.2.384","volume":"17","author":"L O\u2019Connor","year":"1998","unstructured":"O\u2019Connor, L. et al. Bim: a novel member of the Bcl-2 family that promotes apoptosis. EMBO J. 17, 384\u2013395 (1998).","journal-title":"EMBO J."},{"key":"3001_CR54","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s11658-025-00743-5","volume":"30","author":"Y Liu","year":"2025","unstructured":"Liu, Y. et al. Molecular signatures of disulfidptosis: interplay with programmed cell death pathways and therapeutic implications in oncology. Cell. Mol. Biol. Lett. 30, 66 (2025).","journal-title":"Cell. Mol. Biol. Lett."},{"key":"3001_CR55","doi-asserted-by":"publisher","first-page":"167378","DOI":"10.1016\/j.jmb.2021.167378","volume":"434","author":"N Ketelut-Carneiro","year":"2022","unstructured":"Ketelut-Carneiro, N. & Fitzgerald, K. A. Apoptosis, pyroptosis, and necroptosis-oh my! The many ways a cell can die. J. Mol. Biol. 434, 167378 (2022).","journal-title":"J. Mol. Biol."},{"key":"3001_CR56","doi-asserted-by":"publisher","first-page":"8813","DOI":"10.7150\/thno.62521","volume":"11","author":"SK Hsu","year":"2021","unstructured":"Hsu, S. K. et al. Inflammation-related pyroptosis, a novel programmed cell death pathway, and its crosstalk with immune therapy in cancer treatment. Theranostics 11, 8813\u20138835 (2021).","journal-title":"Theranostics"},{"key":"3001_CR57","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41421-020-0167-x","volume":"6","author":"D Zheng","year":"2020","unstructured":"Zheng, D., Liwinski, T. & Elinav, E. Inflammasome activation and regulation: toward a better understanding of complex mechanisms. Cell Discov. 6, 36 (2020).","journal-title":"Cell Discov."},{"key":"3001_CR58","doi-asserted-by":"publisher","first-page":"101781","DOI":"10.1016\/j.smim.2023.101781","volume":"69","author":"SO Vasudevan","year":"2023","unstructured":"Vasudevan, S. O., Behl, B. & Rathinam, V. A. Pyroptosis-induced inflammation and tissue damage. Semin. Immunol. 69, 101781 (2023).","journal-title":"Semin. Immunol."},{"key":"3001_CR59","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1084\/jem.20151613","volume":"213","author":"I Jorgensen","year":"2016","unstructured":"Jorgensen, I., Zhang, Y., Krantz, B. A. & Miao, E. A. Pyroptosis triggers pore-induced intracellular traps (PITs) that capture bacteria and lead to their clearance by efferocytosis. J. Exp. Med. 213, 2113\u20132128 (2016).","journal-title":"J. Exp. Med."},{"key":"3001_CR60","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1002\/eji.201545772","volume":"45","author":"S R\u00fchl","year":"2015","unstructured":"R\u00fchl, S. & Broz, P. Caspase-11 activates a canonical NLRP3 inflammasome by promoting K(+) efflux. Eur. J. Immunol. 45, 2927\u20132936 (2015).","journal-title":"Eur. J. Immunol."},{"key":"3001_CR61","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.492","volume":"11","author":"T Du","year":"2021","unstructured":"Du, T. et al. Pyroptosis, metabolism, and tumor immune microenvironment. Clin. Transl. Med 11, e492 (2021).","journal-title":"Clin. Transl. Med"},{"key":"3001_CR62","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1002\/eji.201545523","volume":"45","author":"JL Schmid-Burgk","year":"2015","unstructured":"Schmid-Burgk, J. L. et al. Caspase-4 mediates non-canonical activation of the NLRP3 inflammasome in human myeloid cells. Eur. J. Immunol. 45, 2911\u20132917 (2015).","journal-title":"Eur. J. Immunol."},{"key":"3001_CR63","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s13046-021-02065-8","volume":"40","author":"R Loveless","year":"2021","unstructured":"Loveless, R., Bloomquist, R. & Teng, Y. Pyroptosis at the forefront of anticancer immunity. J. Exp. Clin. Cancer Res. 40, 264 (2021).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"3001_CR64","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41420-020-00349-0","volume":"6","author":"M Jiang","year":"2020","unstructured":"Jiang, M., Qi, L., Li, L. & Li, Y. The caspase-3\/GSDME signal pathway as a switch between apoptosis and pyroptosis in cancer. Cell Death Discov. 6, 112 (2020).","journal-title":"Cell Death Discov."},{"key":"3001_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2476-2","volume":"11","author":"L Hu","year":"2020","unstructured":"Hu, L. et al. Chemotherapy-induced pyroptosis is mediated by BAK\/BAX-caspase-3-GSDME pathway and inhibited by 2-bromopalmitate. Cell Death Dis. 11, 281 (2020).","journal-title":"Cell Death Dis."},{"key":"3001_CR66","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41420-026-03032-y","volume":"12","author":"H Huang","year":"2026","unstructured":"Huang, H. et al. RRx-001 inhibits G6PD to deplete NADPH and trigger disulfidptosis coupled with DAMP-mediated immunogenic cell death in hepatocellular carcinoma. Cell Death Discov. 12, 194 (2026).","journal-title":"Cell Death Discov."},{"key":"3001_CR67","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s10495-022-01807-z","volume":"28","author":"X Li","year":"2023","unstructured":"Li, X. et al. Pyroptosis in bone loss. Apoptosis 28, 293\u2013312 (2023).","journal-title":"Apoptosis"},{"key":"3001_CR68","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/s41423-022-00905-x","volume":"19","author":"X Wei","year":"2022","unstructured":"Wei, X. et al. Role of pyroptosis in inflammation and cancer. Cell. Mol. Immunol. 19, 971\u2013992 (2022).","journal-title":"Cell. Mol. Immunol."},{"key":"3001_CR69","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1038\/s41401-022-00887-6","volume":"43","author":"F Yang","year":"2022","unstructured":"Yang, F., Bettadapura, S. N., Smeltzer, M. S., Zhu, H. & Wang, S. Pyroptosis and pyroptosis-inducing cancer drugs. Acta Pharmacol. Sin. 43, 2462\u20132473 (2022).","journal-title":"Acta Pharmacol. Sin."},{"key":"3001_CR70","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202500880","volume":"21","author":"W Zhen","year":"2025","unstructured":"Zhen, W., Zhao, T., Chen, X. & Zhang, J. Unlocking the potential of disulfidptosis: nanotechnology-driven strategies for advanced cancer therapy. Small 21, e2500880 (2025).","journal-title":"Small"},{"key":"3001_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53135-2","volume":"15","author":"Y Zhu","year":"2024","unstructured":"Zhu, Y. et al. Intermetallics triggering pyroptosis and disulfidptosis in cancer cells promote anti-tumor immunity. Nat. Commun. 15, 8696 (2024).","journal-title":"Nat. Commun."},{"key":"3001_CR72","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41392-022-01046-3","volume":"7","author":"W Gao","year":"2022","unstructured":"Gao, W., Wang, X., Zhou, Y., Wang, X. & Yu, Y. Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy. Signal Transduct. Target Ther. 7, 196 (2022).","journal-title":"Signal Transduct. Target Ther."},{"key":"3001_CR73","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13045-022-01392-3","volume":"15","author":"X Tong","year":"2022","unstructured":"Tong, X. et al. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research. J. Hematol. Oncol. 15, 174 (2022).","journal-title":"J. Hematol. Oncol."},{"key":"3001_CR74","doi-asserted-by":"publisher","first-page":"E5944","DOI":"10.1073\/pnas.1806973115","volume":"115","author":"P Amin","year":"2018","unstructured":"Amin, P. et al. Regulation of a distinct activated RIPK1 intermediate bridging complex I and complex II in TNF\u03b1-mediated apoptosis. Proc. Natl. Acad. Sci. USA 115, E5944\u2013E5953 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"3001_CR75","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.semcancer.2022.07.007","volume":"86","author":"T Zhang","year":"2022","unstructured":"Zhang, T., Wang, Y., Inuzuka, H. & Wei, W. Necroptosis pathways in tumorigenesis. Semin. Cancer Biol. 86, 32\u201340 (2022).","journal-title":"Semin. Cancer Biol."},{"key":"3001_CR76","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.tcb.2003.12.002","volume":"14","author":"AM Cuervo","year":"2004","unstructured":"Cuervo, A. M. Autophagy: in sickness and in health. Trends Cell Biol. 14, 70\u201377 (2004).","journal-title":"Trends Cell Biol."},{"key":"3001_CR77","doi-asserted-by":"publisher","first-page":"99","DOI":"10.15698\/cst2021.07.253","volume":"5","author":"J Zapata-Mu\u00f1oz","year":"2021","unstructured":"Zapata-Mu\u00f1oz, J., Villarejo-Zori, B., Largo-Barrientos, P. & Boya, P. Towards a better understanding of the neuro-developmental role of autophagy in sickness and in health. Cell Stress 5, 99\u2013118 (2021).","journal-title":"Cell Stress"},{"key":"3001_CR78","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1126\/science.1099993","volume":"306","author":"T Shintani","year":"2004","unstructured":"Shintani, T. & Klionsky, D. J. Autophagy in health and disease: a double-edged sword. Science 306, 990\u2013995 (2004).","journal-title":"Science"},{"key":"3001_CR79","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nrm2245","volume":"8","author":"DJ Klionsky","year":"2007","unstructured":"Klionsky, D. J. Autophagy: from phenomenology to molecular understanding in less than a decade. Nat. Rev. Mol. Cell Biol. 8, 931\u2013937 (2007).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"3001_CR80","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/446745a","volume":"446","author":"B Levine","year":"2007","unstructured":"Levine, B. Cell biology: autophagy and cancer. Nature 446, 745\u2013747 (2007).","journal-title":"Nature"},{"key":"3001_CR81","first-page":"183","volume":"11","author":"SK Goswami","year":"2006","unstructured":"Goswami, S. K. & Das, D. K. Autophagy in the myocardium: dying for survival? Exp. Clin. Cardiol. 11, 183\u2013188 (2006).","journal-title":"Exp. Clin. Cardiol."},{"key":"3001_CR82","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1146\/annurev-cellbio-092910-154005","volume":"27","author":"N Mizushima","year":"2011","unstructured":"Mizushima, N., Yoshimori, T. & Ohsumi, Y. The role of Atg proteins in autophagosome formation. Annu. Rev. Cell Dev. Biol. 27, 107\u2013132 (2011).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"3001_CR83","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.molcel.2013.12.014","volume":"53","author":"V Rogov","year":"2014","unstructured":"Rogov, V., D\u00f6tsch, V., Johansen, T. & Kirkin, V. Interactions between autophagy receptors and ubiquitin-like proteins form the molecular basis for selective autophagy. Mol. Cell. 53, 167\u2013178 (2014).","journal-title":"Mol. Cell."},{"key":"3001_CR84","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41420-025-02495-9","volume":"11","author":"S Wan","year":"2025","unstructured":"Wan, S. et al. Disulfidptosis in tumor progression. Cell Death Discov. 11, 205 (2025).","journal-title":"Cell Death Discov."},{"key":"3001_CR85","doi-asserted-by":"publisher","first-page":"1438807","DOI":"10.3389\/fimmu.2024.1438807","volume":"15","author":"Y Jiang","year":"2024","unstructured":"Jiang, Y. & Sun, M. SLC7A11: the Achilles heel of tumor? Front. Immunol. 15, 1438807 (2024).","journal-title":"Front. Immunol."},{"key":"3001_CR86","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1074\/jbc.274.5.3009","volume":"274","author":"E Nakamura","year":"1999","unstructured":"Nakamura, E. et al. 4F2 (CD98) heavy chain is associated covalently with an amino acid transporter and controls intracellular trafficking and membrane topology of 4F2 heterodimer. J. Biol. Chem. 274, 3009\u20133016 (1999).","journal-title":"J. Biol. Chem."},{"key":"3001_CR87","doi-asserted-by":"publisher","first-page":"722624","DOI":"10.3389\/fonc.2021.722624","volume":"11","author":"J Ding","year":"2021","unstructured":"Ding, J. et al. Knockdown of oligosaccharyltransferase subunit ribophorin 1 induces endoplasmic-reticulum-stress-dependent cell apoptosis in breast cancer. Front. Oncol. 11, 722624 (2021).","journal-title":"Front. Oncol."},{"key":"3001_CR88","doi-asserted-by":"publisher","first-page":"38080","DOI":"10.1074\/jbc.M112.394288","volume":"287","author":"SY Qin","year":"2012","unstructured":"Qin, S. Y. et al. Malectin forms a complex with ribophorin I for enhanced association with misfolded glycoproteins. J. Biol. Chem. 287, 38080\u201338089 (2012).","journal-title":"J. Biol. Chem."},{"key":"3001_CR89","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s12672-024-00875-8","volume":"15","author":"WJ Shen","year":"2024","unstructured":"Shen, W. J. & Zhang, Y. RPN1 promotes the proliferation and invasion of breast cancer cells by activating the PI3K\/AKT\/mTOR signaling pathway. Discov. Oncol. 15, 25 (2024).","journal-title":"Discov. Oncol."},{"key":"3001_CR90","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/sj.emboj.7600084","volume":"23","author":"A Steffen","year":"2004","unstructured":"Steffen, A. et al. Sra-1 and Nap1 link Rac to actin assembly driving lamellipodia formation. EMBO J. 23, 749\u2013759 (2004).","journal-title":"EMBO J."},{"key":"3001_CR91","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/s12276-023-01004-1","volume":"55","author":"KA Han","year":"2023","unstructured":"Han, K. A. & Ko, J. Orchestration of synaptic functions by WAVE regulatory complex-mediated actin reorganization. Exp. Mol. Med. 55, 1065\u20131075 (2023).","journal-title":"Exp. Mol. Med."},{"key":"3001_CR92","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1007\/s10495-024-01989-8","volume":"29","author":"F Xiao","year":"2024","unstructured":"Xiao, F. et al. Disulfidptosis: a new type of cell death. Apoptosis 29, 1309\u20131329 (2024).","journal-title":"Apoptosis"},{"key":"3001_CR93","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-024-00593-x","volume":"12","author":"J Chen","year":"2024","unstructured":"Chen, J. et al. Disulfidptosis decoded: a journey through cell death mysteries, regulatory networks, disease paradigms and future directions. Biomark. Res. 12, 45 (2024).","journal-title":"Biomark. Res."},{"key":"3001_CR94","doi-asserted-by":"publisher","first-page":"414","DOI":"10.14348\/molcells.2023.0060","volume":"46","author":"D Shao","year":"2023","unstructured":"Shao, D., Shi, L. & Ji, H. Disulfidptosis: disulfide stress mediates a novel cell death pathway via actin cytoskeletal vulnerability. Mol. Cells 46, 414\u2013416 (2023).","journal-title":"Mol. Cells"},{"key":"3001_CR95","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s43556-023-00132-4","volume":"4","author":"Y Meng","year":"2023","unstructured":"Meng, Y., Chen, X. & Deng, G. Disulfidptosis: a new form of regulated cell death for cancer treatment. Mol. Biomed. 4, 18 (2023).","journal-title":"Mol. Biomed."},{"key":"3001_CR96","doi-asserted-by":"publisher","first-page":"917","DOI":"10.14336\/AD.2024.0083","volume":"16","author":"Q Gu","year":"2024","unstructured":"Gu, Q. et al. Disulfidptosis, a novel cell death pathway: molecular landscape and therapeutic implications. Aging Dis. 16, 917\u2013945 (2024).","journal-title":"Aging Dis."},{"key":"3001_CR97","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202408789","volume":"12","author":"J Wang","year":"2025","unstructured":"Wang, J. et al. Inhibition of endoplasmic reticulum stress cooperates with SLC7A11 to promote disulfidptosis and suppress tumor growth upon glucose limitation. Adv. Sci. 12, e2408789 (2025).","journal-title":"Adv. Sci."},{"key":"3001_CR98","doi-asserted-by":"publisher","first-page":"377","DOI":"10.21037\/jgo-23-949","volume":"15","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. Disulfidptosis-related genes of prognostic signature and immune infiltration features in hepatocellular carcinoma supported by bulk and single-cell RNA sequencing data. J. Gastrointest. Oncol. 15, 377\u2013396 (2024).","journal-title":"J. Gastrointest. Oncol."},{"key":"3001_CR99","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s12672-025-01875-y","volume":"16","author":"Y Chen","year":"2025","unstructured":"Chen, Y., Zhang, D., Yang, H., Wu, J. & He, W. Advances in the study of disulfidptosis in digestive tract tumors. Discov. Oncol. 16, 186 (2025).","journal-title":"Discov. Oncol."},{"key":"3001_CR100","doi-asserted-by":"publisher","first-page":"1412277","DOI":"10.3389\/fimmu.2024.1412277","volume":"15","author":"H Zheng","year":"2024","unstructured":"Zheng, H. et al. A disulfidptosis-related lncRNA signature for analyzing tumor microenvironment and clinical prognosis in hepatocellular carcinoma. Front. Immunol. 15, 1412277 (2024).","journal-title":"Front. Immunol."},{"key":"3001_CR101","doi-asserted-by":"publisher","first-page":"9450","DOI":"10.3390\/cimb45120593","volume":"45","author":"L Ni","year":"2023","unstructured":"Ni, L., Yu, Q., You, R., Chen, C. & Peng, B. Development of the RF-GSEA method for identifying disulfidptosis-related genes and application in hepatocellular carcinoma. Curr. Issues Mol. Biol. 45, 9450\u20139470 (2023).","journal-title":"Curr. Issues Mol. Biol."},{"key":"3001_CR102","doi-asserted-by":"publisher","first-page":"1294677","DOI":"10.3389\/fimmu.2023.1294677","volume":"14","author":"T Yang","year":"2023","unstructured":"Yang, T. et al. Integrative analysis of disulfidptosis and immune microenvironment in hepatocellular carcinoma: a putative model and immunotherapeutic strategies. Front. Immunol. 14, 1294677 (2023).","journal-title":"Front. Immunol."},{"key":"3001_CR103","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.freeradbiomed.2019.05.020","volume":"157","author":"KC Park","year":"2020","unstructured":"Park, K. C., Paluncic, J., Kovacevic, Z. & Richardson, D. R. Pharmacological targeting and the diverse functions of the metastasis suppressor, NDRG1, in cancer. Free Radic. Biol. Med. 157, 154\u2013175 (2020).","journal-title":"Free Radic. Biol. Med."},{"key":"3001_CR104","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1016\/j.bbadis.2018.04.011","volume":"1864","author":"KC Park","year":"2018","unstructured":"Park, K. C. et al. Identification of differential phosphorylation and sub-cellular localization of the metastasis suppressor, NDRG1. Biochim. Biophys. Acta Mol. Basis Dis. 1864, 2644\u20132663 (2018).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"3001_CR105","doi-asserted-by":"publisher","first-page":"12843","DOI":"10.1007\/s00432-023-05076-4","volume":"149","author":"Y Chen","year":"2023","unstructured":"Chen, Y., Xue, W., Zhang, Y., Gao, Y. & Wang, Y. A novel disulfidptosis-related immune checkpoint genes signature: forecasting the prognosis of hepatocellular carcinoma. J. Cancer Res. Clin. Oncol. 149, 12843\u201312854 (2023).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"3001_CR106","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/carcin\/bgae003","volume":"45","author":"J Wei","year":"2024","unstructured":"Wei, J. et al. Functional genetic variants of the disulfidptosis-related INF2 gene predict survival of hepatitis B virus-related hepatocellular carcinoma. Carcinogenesis 45, 199\u2013209 (2024).","journal-title":"Carcinogenesis"},{"key":"3001_CR107","doi-asserted-by":"publisher","first-page":"1204338","DOI":"10.3389\/fimmu.2023.1204338","volume":"14","author":"Z Wang","year":"2023","unstructured":"Wang, Z. et al. Based on disulfidptosis-related glycolytic genes to construct a signature for predicting prognosis and immune infiltration analysis of hepatocellular carcinoma. Front. Immunol. 14, 1204338 (2023).","journal-title":"Front. Immunol."},{"key":"3001_CR108","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e19502","volume":"9","author":"C Fu","year":"2023","unstructured":"Fu, C., Cheng, C. & Zhang, Y. A novel signature of the ligand and receptor genes associated with disulfidoptosis for prediction of prognosis, immunologic therapy responses in hepatocellular carcinoma. Heliyon 9, e19502 (2023).","journal-title":"Heliyon"},{"key":"3001_CR109","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.16819","volume":"12","author":"J Wei","year":"2024","unstructured":"Wei, J., Wang, J., Chen, X., Zhang, L. & Peng, M. Novel application of the ferroptosis-related genes risk model associated with disulfidptosis in hepatocellular carcinoma prognosis and immune infiltration. PeerJ 12, e16819 (2024).","journal-title":"PeerJ"},{"key":"3001_CR110","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10495-023-01900-x","volume":"29","author":"C Zhang","year":"2024","unstructured":"Zhang, C. et al. Development and experimental validation of a machine learning-based disulfidptosis-related ferroptosis score for hepatocellular carcinoma. Apoptosis 29, 103\u2013120 (2024).","journal-title":"Apoptosis"},{"key":"3001_CR111","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1002\/tox.23904","volume":"39","author":"Z Tao","year":"2024","unstructured":"Tao, Z., Huang, J. & Li, J. Comprehensive intratumoral heterogeneity landscaping of liver hepatocellular carcinoma and discerning of APLP2 in cancer progression. Environ. Toxicol. 39, 612\u2013625 (2024).","journal-title":"Environ. Toxicol."},{"key":"3001_CR112","doi-asserted-by":"publisher","first-page":"110368","DOI":"10.1016\/j.intimp.2023.110368","volume":"120","author":"T Wang","year":"2023","unstructured":"Wang, T. et al. Disulfidptosis classification of hepatocellular carcinoma reveals correlation with clinical prognosis and immune profile. Int. Immunopharmacol. 120, 110368 (2023).","journal-title":"Int. Immunopharmacol."},{"key":"3001_CR113","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/cac2.12108","volume":"41","author":"YT Tan","year":"2021","unstructured":"Tan, Y. T. et al. LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer. Cancer Commun. 41, 109\u2013120 (2021).","journal-title":"Cancer Commun."},{"key":"3001_CR114","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-01988-y","volume":"23","author":"YT Chan","year":"2024","unstructured":"Chan, Y. T. et al. Loss of lncRNA LINC01056 leads to sorafenib resistance in HCC. Mol. Cancer 23, 74 (2024).","journal-title":"Mol. Cancer"},{"key":"3001_CR115","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/nm.3981","volume":"21","author":"M Huarte","year":"2015","unstructured":"Huarte, M. The emerging role of lncRNAs in cancer. Nat. Med. 21, 1253\u20131261 (2015).","journal-title":"Nat. Med."},{"key":"3001_CR116","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40880-019-0348-x","volume":"39","author":"J Luo","year":"2019","unstructured":"Luo, J., Langer, L. F. & Liu, J. A novel role of LncRNA in regulating tumor metabolism and angiogenesis under hypoxia. Cancer Commun. 39, 2 (2019).","journal-title":"Cancer Commun."},{"key":"3001_CR117","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrm.2017.104","volume":"19","author":"JD Ransohoff","year":"2018","unstructured":"Ransohoff, J. D., Wei, Y. & Khavari, P. A. The functions and unique features of long intergenic non-coding RNA. Nat. Rev. Mol. Cell Biol. 19, 143\u2013157 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"3001_CR118","first-page":"249","volume":"15","author":"Q Wei","year":"2023","unstructured":"Wei, Q. et al. Disulfidptosis-associated lncRNAs are potential biomarkers for predicting immune response and prognosis within individuals diagnosed with hepatocellular carcinoma. Hepat. Med. 15, 249\u2013264 (2023).","journal-title":"Hepat. Med."},{"key":"3001_CR119","doi-asserted-by":"publisher","first-page":"17626","DOI":"10.3390\/ijms242417626","volume":"24","author":"X Jia","year":"2023","unstructured":"Jia, X., Wang, Y., Yang, Y., Fu, Y. & Liu, Y. Constructed risk prognosis model associated with disulfidptosis lncRNAs in HCC. Int. J. Mol. Sci. 24, 17626 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"3001_CR120","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1086-z","volume":"18","author":"L Wei","year":"2019","unstructured":"Wei, L. et al. The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma. Mol. Cancer 18, 147 (2019).","journal-title":"Mol. Cancer"},{"key":"3001_CR121","doi-asserted-by":"publisher","first-page":"49986","DOI":"10.1021\/acsomega.4c09411","volume":"9","author":"X Gu","year":"2024","unstructured":"Gu, X. et al. Systematic analysis of disulfidptosis-related lncRNAs in hepatocellular carcinoma with vascular invasion revealed that AC131009.1 can promote HCC invasion and metastasis through epithelial-mesenchymal transition. ACS Omega 9, 49986\u201349999 (2024).","journal-title":"ACS Omega"},{"key":"3001_CR122","doi-asserted-by":"publisher","first-page":"20240919","DOI":"10.1515\/med-2024-0919","volume":"19","author":"H Wang","year":"2024","unstructured":"Wang, H. & Wang, W. Unlocking the future of hepatocellular carcinoma treatment: a comprehensive analysis of disulfidptosis-related lncRNAs for prognosis and drug screening. Open Med. 19, 20240919 (2024).","journal-title":"Open Med."},{"key":"3001_CR123","doi-asserted-by":"publisher","first-page":"7053","DOI":"10.21037\/tcr-2025-610","volume":"14","author":"XF Gao","year":"2025","unstructured":"Gao, X. F. et al. A novel disulfidptosis-related lncRNAs index to predict prognosis and therapeutic target in hepatocellular carcinoma. Transl. Cancer Res. 14, 7053\u20137070 (2025).","journal-title":"Transl. Cancer Res."},{"key":"3001_CR124","doi-asserted-by":"publisher","first-page":"1409149","DOI":"10.3389\/fimmu.2024.1409149","volume":"15","author":"R Yang","year":"2024","unstructured":"Yang, R. et al. Role of disulfidptosis in colorectal adenocarcinoma: implications for prognosis and immunity. Front. Immunol. 15, 1409149 (2024).","journal-title":"Front. Immunol."},{"key":"3001_CR125","doi-asserted-by":"publisher","first-page":"5539","DOI":"10.7150\/ijbs.71809","volume":"18","author":"F Lu","year":"2022","unstructured":"Lu, F. et al. Thioredoxin 1 supports colorectal cancer cell survival and promotes migration and invasion under glucose deprivation through interaction with G6PD. Int. J. Biol. Sci. 18, 5539\u20135553 (2022).","journal-title":"Int. J. Biol. Sci."},{"key":"3001_CR126","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s11658-025-00761-3","volume":"30","author":"Q Li","year":"2025","unstructured":"Li, Q. et al. FLNA, a disulfidptosis-related gene, modulates tumor immunity and progression in colorectal cancer. Cell. Mol. Biol. Lett. 30, 92 (2025).","journal-title":"Cell. Mol. Biol. Lett."},{"key":"3001_CR127","doi-asserted-by":"publisher","first-page":"1344637","DOI":"10.3389\/fimmu.2024.1344637","volume":"15","author":"M Li","year":"2024","unstructured":"Li, M. et al. Identifying and evaluating a disulfidptosis-related gene signature to predict prognosis in colorectal adenocarcinoma patients. Front. Immunol. 15, 1344637 (2024).","journal-title":"Front. Immunol."},{"key":"3001_CR128","doi-asserted-by":"publisher","first-page":"12915","DOI":"10.3390\/ijms241612915","volume":"24","author":"X Dong","year":"2023","unstructured":"Dong, X. et al. Construction and validation of a reliable disulfidptosis-related LncRNAs signature of the subtype, prognostic, and immune landscape in colon cancer. Int. J. Mol. Sci. 24, 12915 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"3001_CR129","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1007\/s10495-024-02011-x","volume":"29","author":"K Wang","year":"2024","unstructured":"Wang, K. et al. Disulfidptosis-related long non-coding RNA signature predicts the prognosis, tumor microenvironment, immunotherapy, and antitumor drug options in colon adenocarcinoma. Apoptosis 29, 2074\u20132090 (2024).","journal-title":"Apoptosis"},{"key":"3001_CR130","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1186\/s12876-023-03020-x","volume":"23","author":"P Chen","year":"2023","unstructured":"Chen, P., Yu, J., Luo, Q., Li, J. & Wang, W. Construction of disulfidptosis-related lncRNA signature for predicting the prognosis and immune escape in colon adenocarcinoma. BMC Gastroenterol. 23, 382 (2023).","journal-title":"BMC Gastroenterol."},{"key":"3001_CR131","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12723","volume":"53","author":"X Ni","year":"2020","unstructured":"Ni, X. et al. Long non-coding RNA ZEB1-AS1 promotes colon adenocarcinoma malignant progression via miR-455-3p\/PAK2 axis. Cell Prolif. 53, e12723 (2020).","journal-title":"Cell Prolif."},{"key":"3001_CR132","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1049\/syb2.12089","volume":"18","author":"Q Fan","year":"2024","unstructured":"Fan, Q. et al. Analysis of disulfidptosis- and cuproptosis-related LncRNAs in modulating the immune microenvironment and chemosensitivity in colon adenocarcinoma. IET Syst. Biol. 18, 55\u201375 (2024).","journal-title":"IET Syst. Biol."},{"key":"3001_CR133","doi-asserted-by":"publisher","first-page":"89","DOI":"10.5306\/wjco.v15.i1.89","volume":"15","author":"KL Wang","year":"2024","unstructured":"Wang, K. L. et al. Predicting colorectal cancer prognosis based on long noncoding RNAs of disulfidptosis genes. World J. Clin. Oncol. 15, 89\u2013114 (2024).","journal-title":"World J. Clin. Oncol."},{"key":"3001_CR134","doi-asserted-by":"publisher","first-page":"373","DOI":"10.5306\/wjco.v14.i10.373","volume":"14","author":"Q Li","year":"2023","unstructured":"Li, Q. & Yin, L. K. Comprehensive analysis of disulfidptosis related genes and prognosis of gastric cancer. World J. Clin. Oncol. 14, 373\u2013399 (2023).","journal-title":"World J. Clin. Oncol."},{"key":"3001_CR135","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1007\/s12094-024-03457-w","volume":"26","author":"Z Liao","year":"2024","unstructured":"Liao, Z. & Xie, Z. Construction of a disulfidptosis-related glycolysis gene risk model to predict the prognosis and immune infiltration analysis of gastric adenocarcinoma. Clin. Transl. Oncol. 26, 2309\u20132322 (2024).","journal-title":"Clin. Transl. Oncol."},{"key":"3001_CR136","doi-asserted-by":"publisher","first-page":"e26013","DOI":"10.1016\/j.heliyon.2024.e26013","volume":"10","author":"X Liu","year":"2024","unstructured":"Liu, X. & Ou, J. The development of prognostic gene markers associated with disulfidptosis in gastric cancer and their application in predicting drug response. Heliyon 10, e26013 (2024).","journal-title":"Heliyon"},{"key":"3001_CR137","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.3390\/biomedicines11123165","volume":"11","author":"K Kang","year":"2023","unstructured":"Kang, K., Li, X., Peng, Y. & Zhou, Y. Comprehensive analysis of disulfidptosis-related LncRNAs in molecular classification, immune microenvironment characterization and prognosis of gastric cancer. Biomedicines 11, 3165 (2023).","journal-title":"Biomedicines"},{"key":"3001_CR138","doi-asserted-by":"publisher","first-page":"1568976","DOI":"10.3389\/fimmu.2025.1568976","volume":"16","author":"R Cui","year":"2025","unstructured":"Cui, R. et al. Prognostic and immunotherapeutic potential of disulfidptosis-associated signature in pancreatic cancer. Front. Immunol. 16, 1568976 (2025).","journal-title":"Front. Immunol."},{"key":"3001_CR139","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.21037\/tcr-24-1976","volume":"14","author":"X Jin","year":"2025","unstructured":"Jin, X. et al. Comprehensive assessment of disulfidptosis-related long non-coding RNA index as biomarkers for predicting clinical outcomes and immune microenvironment in pancreatic cancer. Transl. Cancer Res. 14, 2758\u20132778 (2025).","journal-title":"Transl. Cancer Res."},{"key":"3001_CR140","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1007\/s12033-024-01131-8","volume":"67","author":"H Duan","year":"2024","unstructured":"Duan, H. et al. Prognostic model construction of disulfidptosis-related genes and targeted anticancer drug research in pancreatic cancer. Mol. Biotechnol. 67, 1463\u20131482 (2024).","journal-title":"Mol. Biotechnol."},{"key":"3001_CR141","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.21037\/tcr-23-1706","volume":"13","author":"J Guo","year":"2024","unstructured":"Guo, J., Wang, Y., Hou, J., Zhao, T. & Wei, Z. Comprehensive analysis of disulfidptosis-related lncRNAs for predicting prognosis and response of immunotherapy in pancreatic adenocarcinoma. Transl. Cancer Res. 13, 1336\u20131350 (2024).","journal-title":"Transl. Cancer Res."},{"key":"3001_CR142","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1007\/s12033-023-00875-z","volume":"66","author":"F Xing","year":"2024","unstructured":"Xing, F., Qin, Y., Xu, J., Wang, W. & Zhang, B. Construction of a novel disulfidptosis-related lncRNA prognostic signature in pancreatic cancer. Mol. Biotechnol. 66, 2396\u20132414 (2024).","journal-title":"Mol. Biotechnol."},{"key":"3001_CR143","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s12672-023-00711-5","volume":"14","author":"F Liu","year":"2023","unstructured":"Liu, F. et al. A demonstration based on multi-omics transcriptome sequencing data revealed disulfidptosis heterogeneity within the tumor microenvironment of esophageal squamous cell carcinoma. Discov. Oncol. 14, 96 (2023).","journal-title":"Discov. Oncol."},{"key":"3001_CR144","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1186\/s12876-025-03768-4","volume":"25","author":"Y Cui","year":"2025","unstructured":"Cui, Y., Deng, Y., Wu, Z. & Sun, X. To verify the biological characteristics of disulfidptosis associated gene ADORA2B in esophageal cancer. BMC Gastroenterol. 25, 382 (2025).","journal-title":"BMC Gastroenterol."},{"key":"3001_CR145","doi-asserted-by":"publisher","first-page":"2432211","DOI":"10.1080\/20565623.2024.2432211","volume":"10","author":"X Xu","year":"2024","unstructured":"Xu, X., Zhang, B., Zhang, J. & Ma, H. Unraveling disulfidptosis for prognostic modeling and personalized treatment strategies in lung adenocarcinoma. Future Sci. OA 10, 2432211 (2024).","journal-title":"Future Sci. OA"},{"key":"3001_CR146","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50157-8","volume":"15","author":"T Lan","year":"2024","unstructured":"Lan, T. et al. Glucose-6-phosphate dehydrogenase maintains redox homeostasis and biosynthesis in LKB1-deficient KRAS-driven lung cancer. Nat. Commun. 15, 5857 (2024).","journal-title":"Nat. Commun."},{"key":"3001_CR147","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e25144","volume":"10","author":"Q Wu","year":"2024","unstructured":"Wu, Q. et al. HuaChanSu suppresses the growth of hepatocellular carcinoma cells by interfering with pentose phosphate pathway through down-regulation of G6PD enzyme activity and expression. Heliyon 10, e25144 (2024).","journal-title":"Heliyon"},{"key":"3001_CR148","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-008441","volume":"12","author":"M Nakamura","year":"2024","unstructured":"Nakamura, M. et al. Blockade of glucose-6-phosphate dehydrogenase induces immunogenic cell death and accelerates immunotherapy. J. Immunother. Cancer 12, e008441 (2024).","journal-title":"J. Immunother. Cancer"},{"key":"3001_CR149","doi-asserted-by":"publisher","first-page":"796","DOI":"10.21147\/j.issn.1000-9604.2025.05.11","volume":"37","author":"W Xia","year":"2025","unstructured":"Xia, W. et al. Molecular subtypes and prognostic signature rooted in disulfidptosis highlight tumor microenvironment in lung adenocarcinoma. Chin. J. Cancer Res. 37, 796\u2013820 (2025).","journal-title":"Chin. J. Cancer Res."},{"key":"3001_CR150","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1093\/annonc\/mdt293","volume":"24","author":"R Noro","year":"2013","unstructured":"Noro, R. et al. Distinct outcome of stage I lung adenocarcinoma with ACTN4 cell motility gene amplification. Ann. Oncol. 24, 2594\u20132600 (2013).","journal-title":"Ann. Oncol."},{"key":"3001_CR151","doi-asserted-by":"publisher","first-page":"4034","DOI":"10.2174\/0109298673313281240425050032","volume":"31","author":"J Liu","year":"2024","unstructured":"Liu, J., Li, H., Zhang, N., Dong, Q. & Liang, Z. Multiomics analysis of disulfidptosis patterns and integrated machine learning to predict immunotherapy response in lung adenocarcinoma. Curr. Med. Chem. 31, 4034\u20134055 (2024).","journal-title":"Curr. Med. Chem."},{"key":"3001_CR152","doi-asserted-by":"publisher","first-page":"1233260","DOI":"10.3389\/fimmu.2023.1233260","volume":"14","author":"Y Wang","year":"2023","unstructured":"Wang, Y., Xu, Y., Liu, C., Yuan, C. & Zhang, Y. Identification of disulfidptosis-related subgroups and prognostic signatures in lung adenocarcinoma using machine learning and experimental validation. Front. Immunol. 14, 1233260 (2023).","journal-title":"Front. Immunol."},{"key":"3001_CR153","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e23502","volume":"10","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. Identification and validation of a disulfidptosis-related genes prognostic signature in lung adenocarcinoma. Heliyon 10, e23502 (2024).","journal-title":"Heliyon"},{"key":"3001_CR154","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.celrep.2013.09.015","volume":"5","author":"JA Wawrzyniak","year":"2013","unstructured":"Wawrzyniak, J. A. et al. A purine nucleotide biosynthesis enzyme guanosine monophosphate reductase is a suppressor of melanoma invasion. Cell Rep. 5, 493\u2013507 (2013).","journal-title":"Cell Rep."},{"key":"3001_CR155","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e35657","volume":"10","author":"L Zhang","year":"2024","unstructured":"Zhang, L., Wang, S. & Wang, L. Construction of lncRNA prognostic model related to disulfidptosis in lung adenocarcinoma. Heliyon 10, e35657 (2024).","journal-title":"Heliyon"},{"key":"3001_CR156","doi-asserted-by":"publisher","first-page":"6670514","DOI":"10.1155\/2023\/6670514","volume":"2023","author":"Z Yang","year":"2023","unstructured":"Yang, Z., Cao, S., Wang, F., Du, K. & Hu, F. Characterization and prognosis of biological microenvironment in lung adenocarcinoma through a disulfidptosis-related lncRNAs signature. Genet Res. 2023, 6670514 (2023).","journal-title":"Genet Res."},{"key":"3001_CR157","doi-asserted-by":"publisher","first-page":"1254119","DOI":"10.3389\/fphar.2023.1254119","volume":"14","author":"HB Zhang","year":"2023","unstructured":"Zhang, H. B., Pan, J. Y. & Zhu, T. A disulfidptosis-related lncRNA prognostic model to predict survival and response to immunotherapy in lung adenocarcinoma. Front. Pharmacol. 14, 1254119 (2023).","journal-title":"Front. Pharmacol."},{"key":"3001_CR158","doi-asserted-by":"publisher","first-page":"111105","DOI":"10.1016\/j.cellsig.2024.111105","volume":"117","author":"C Ma","year":"2024","unstructured":"Ma, C. et al. Deciphering disulfidptosis: uncovering a lncRNA-based signature for prognostic assessment, personalized immunotherapy, and therapeutic agent selection in lung adenocarcinoma patients. Cell. Signal. 117, 111105 (2024).","journal-title":"Cell. Signal."},{"key":"3001_CR159","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-024-01632-y","volume":"16","author":"F Zhao","year":"2024","unstructured":"Zhao, F. et al. Molecular map of disulfidptosis-related genes in lung adenocarcinoma: the perspective toward immune microenvironment and prognosis. Clin. Epigenet. 16, 26 (2024).","journal-title":"Clin. Epigenet."},{"key":"3001_CR160","doi-asserted-by":"publisher","first-page":"1205250","DOI":"10.3389\/fimmu.2023.1205250","volume":"14","author":"K Xu","year":"2023","unstructured":"Xu, K. et al. Identification of disulfidptosis related subtypes, characterization of tumor microenvironment infiltration, and development of DRG prognostic prediction model in RCC, in which MSH3 is a key gene during disulfidptosis. Front. Immunol. 14, 1205250 (2023).","journal-title":"Front. Immunol."},{"key":"3001_CR161","doi-asserted-by":"publisher","first-page":"1288240","DOI":"10.3389\/fimmu.2024.1288240","volume":"15","author":"K Xu","year":"2024","unstructured":"Xu, K. et al. Single-cell disulfidptosis regulator patterns guide intercellular communication of tumor microenvironment that contribute to kidney renal clear cell carcinoma progression and immunotherapy. Front. Immunol. 15, 1288240 (2024).","journal-title":"Front. Immunol."},{"key":"3001_CR162","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s10495-023-01933-2","volume":"29","author":"Y Ye","year":"2024","unstructured":"Ye, Y., Zeng, S. & Hu, X. Unveiling the hidden role of disulfidptosis in kidney renal clear cell carcinoma: a prognostic signature for personalized treatment. Apoptosis 29, 693\u2013708 (2024).","journal-title":"Apoptosis"},{"key":"3001_CR163","doi-asserted-by":"publisher","first-page":"13793","DOI":"10.1007\/s00432-023-05201-3","volume":"149","author":"K Peng","year":"2023","unstructured":"Peng, K. et al. Identification of disulfidptosis-related subtypes and development of a prognosis model based on stacking framework in renal clear cell carcinoma. J. Cancer Res. Clin. Oncol. 149, 13793\u201313810 (2023).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"3001_CR164","doi-asserted-by":"publisher","first-page":"9787","DOI":"10.1007\/s00432-023-04877-x","volume":"149","author":"L Yang","year":"2023","unstructured":"Yang, L. et al. Based on disulfidptosis, revealing the prognostic and immunological characteristics of renal cell carcinoma with tumor thrombus of vena cava and identifying potential therapeutic target AJAP1. J. Cancer Res. Clin. Oncol. 149, 9787\u20139804 (2023).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"3001_CR165","doi-asserted-by":"publisher","DOI":"10.1186\/s13062-024-00517-7","volume":"19","author":"K Xu","year":"2024","unstructured":"Xu, K. et al. Disulfidptosis-associated LncRNA signature predicts prognosis and immune response in kidney renal clear cell carcinoma. Biol. Direct 19, 71 (2024).","journal-title":"Biol. Direct"},{"key":"3001_CR166","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3608","volume":"26","author":"Z Sun","year":"2024","unstructured":"Sun, Z. et al. Investigating the prognostic role of lncRNAs associated with disulfidptosis-related genes in clear cell renal cell carcinoma. J. Gene Med. 26, e3608 (2024).","journal-title":"J. Gene Med."},{"key":"3001_CR167","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-024-10307-0","volume":"25","author":"L Ren","year":"2024","unstructured":"Ren, L. et al. Crosstalk of disulfidptosis-related subtypes identifying a prognostic signature to improve prognosis and immunotherapy responses of clear cell renal cell carcinoma patients. BMC Genomics 25, 413 (2024).","journal-title":"BMC Genomics"},{"key":"3001_CR168","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s12672-025-01994-6","volume":"16","author":"X Wen","year":"2025","unstructured":"Wen, X. et al. Disulfidptosis, a novel regulated cell death to predict survival and therapeutic response in kidney renal clear cell carcinoma. Discov. Oncol. 16, 589 (2025).","journal-title":"Discov. Oncol."},{"key":"3001_CR169","doi-asserted-by":"publisher","first-page":"1198878","DOI":"10.3389\/fimmu.2023.1198878","volume":"14","author":"H Chen","year":"2023","unstructured":"Chen, H., Yang, W., Li, Y., Ma, L. & Ji, Z. Leveraging a disulfidptosis-based signature to improve the survival and drug sensitivity of bladder cancer patients. Front. Immunol. 14, 1198878 (2023).","journal-title":"Front. Immunol."},{"key":"3001_CR170","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e25573","volume":"10","author":"G Pan","year":"2024","unstructured":"Pan, G., Xie, H. & Xia, Y. Disulfidptosis characterizes the tumor microenvironment and predicts immunotherapy sensitivity and prognosis in bladder cancer. Heliyon 10, e25573 (2024).","journal-title":"Heliyon"},{"key":"3001_CR171","doi-asserted-by":"publisher","first-page":"13925","DOI":"10.1007\/s00432-023-05235-7","volume":"149","author":"S Xin","year":"2023","unstructured":"Xin, S. et al. A novel model based on disulfidptosis-related genes to predict prognosis and therapy of bladder urothelial carcinoma. J. Cancer Res. Clin. Oncol. 149, 13925\u201313942 (2023).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"3001_CR172","doi-asserted-by":"crossref","unstructured":"Zhao, S. et al. Crosstalk of disulfidptosis-related subtypes, establishment of a prognostic signature and immune infiltration characteristics in bladder cancer based on a machine learning survival framework. Front. Endocrinol. 14, 1180404 (2023).","DOI":"10.3389\/fendo.2023.1180404"},{"key":"3001_CR173","doi-asserted-by":"publisher","first-page":"15805","DOI":"10.1007\/s00432-023-05352-3","volume":"149","author":"C Ren","year":"2023","unstructured":"Ren, C. et al. Development and validation of a disulfidptosis and M2 TAM-related classifier for bladder cancer to explore tumor subtypes, immune landscape and drug treatment. J. Cancer Res. Clin. Oncol. 149, 15805\u201315818 (2023).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"3001_CR174","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1006\/geno.1993.1092","volume":"15","author":"M Lehto","year":"1993","unstructured":"Lehto, M. et al. Assignment of the gene encoding glycogen synthase (GYS) to human chromosome 19, band q13.3. Genomics 15, 460\u2013461 (1993).","journal-title":"Genomics"},{"key":"3001_CR175","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.502","volume":"5","author":"J Xie","year":"2024","unstructured":"Xie, J. et al. Multi-omics analysis of disulfidptosis regulators and therapeutic potential reveals glycogen synthase 1 as a disulfidptosis triggering target for triple-negative breast cancer. MedComm 5, e502 (2024).","journal-title":"MedComm"},{"key":"3001_CR176","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12905-023-02823-0","volume":"24","author":"S Chen","year":"2024","unstructured":"Chen, S., Li, X. & Ao, W. Prognostic and immune infiltration features of disulfidptosis-related subtypes in breast cancer. BMC Womens. Health 24, 6 (2024).","journal-title":"BMC Womens. Health"},{"key":"3001_CR177","doi-asserted-by":"publisher","first-page":"1198826","DOI":"10.3389\/fimmu.2023.1198826","volume":"14","author":"J Liang","year":"2023","unstructured":"Liang, J. et al. Identification of disulfidptosis-related subtypes, characterization of tumor microenvironment infiltration, and development of a prognosis model in breast cancer. Front. Immunol. 14, 1198826 (2023).","journal-title":"Front. Immunol."},{"key":"3001_CR178","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1002\/tox.24043","volume":"39","author":"X Tang","year":"2024","unstructured":"Tang, X., Ping, B., Liu, Y. & Zhou, Y. Novel disulfidptosis-derived gene blueprint stratifying patients with breast cancer. Environ. Toxicol. 39, 1715\u20131728 (2024).","journal-title":"Environ. Toxicol."},{"key":"3001_CR179","doi-asserted-by":"publisher","first-page":"1193944","DOI":"10.3389\/fgene.2023.1193944","volume":"14","author":"Z Wang","year":"2023","unstructured":"Wang, Z. et al. A novel disulfidptosis-associated expression pattern in breast cancer based on machine learning. Front Genet 14, 1193944 (2023).","journal-title":"Front Genet"},{"key":"3001_CR180","doi-asserted-by":"crossref","unstructured":"Chen, X., Hu, G. & Yu, Q. Impact of disulfidptosis-associated clusters on breast cancer survival rates and guiding personalized treatment. Front. Endocrinol. 14, 1256132 (2023).","DOI":"10.3389\/fendo.2023.1256132"},{"key":"3001_CR181","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-023-02073-y","volume":"40","author":"Y Wang","year":"2023","unstructured":"Wang, Y., Deng, Y., Xie, H. & Cao, S. Hub gene of disulfidptosis-related immune checkpoints in breast cancer. Med. Oncol. 40, 222 (2023).","journal-title":"Med. Oncol."},{"key":"3001_CR182","doi-asserted-by":"publisher","first-page":"12145","DOI":"10.1007\/s00432-023-05109-y","volume":"149","author":"Y Chen","year":"2023","unstructured":"Chen, Y. et al. Single-cell sequencing and bulk RNA data reveal the tumor microenvironment infiltration characteristics of disulfidptosis related genes in breast cancer. J. Cancer Res. Clin. Oncol. 149, 12145\u201312164 (2023).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"3001_CR183","doi-asserted-by":"publisher","first-page":"16511","DOI":"10.1007\/s00432-023-05378-7","volume":"149","author":"L Xu","year":"2023","unstructured":"Xu, L. et al. Machine learning- and WGCNA-mediated double analysis based on genes associated with disulfidptosis, cuproptosis and ferroptosis for the construction and validation of the prognostic model for breast cancer. J. Cancer Res. Clin. Oncol. 149, 16511\u201316523 (2023).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"3001_CR184","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature11412","volume":"490","author":"CGA Network","year":"2012","unstructured":"Network, C. G. A. Comprehensive molecular portraits of human breast tumours. Nature 490, 61\u201370 (2012).","journal-title":"Nature"},{"key":"3001_CR185","doi-asserted-by":"publisher","first-page":"16851","DOI":"10.1007\/s00432-023-05372-z","volume":"149","author":"S Liu","year":"2023","unstructured":"Liu, S. et al. Integrative landscape analysis of prognostic model biomarkers and immunogenomics of disulfidptosis-related genes in breast cancer based on LASSO and WGCNA analyses. J. Cancer Res. Clin. Oncol. 149, 16851\u201316867 (2023).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"3001_CR186","doi-asserted-by":"publisher","first-page":"101938","DOI":"10.1016\/j.tranon.2024.101938","volume":"44","author":"T Jin","year":"2024","unstructured":"Jin, T. et al. Exploring the role of disulfidptosis-related signatures in immune microenvironment, prognosis and therapeutic strategies of cervical cancer. Transl. Oncol. 44, 101938 (2024).","journal-title":"Transl. Oncol."},{"key":"3001_CR187","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/nature21386","volume":"543","author":"CGAR Network","year":"2017","unstructured":"Network, C. G. A. R. Integrated genomic and molecular characterization of cervical cancer. Nature 543, 378\u2013384 (2017).","journal-title":"Nature"},{"key":"3001_CR188","doi-asserted-by":"publisher","first-page":"20","DOI":"10.14715\/cmb\/2025.71.3.3","volume":"71","author":"L Hong","year":"2025","unstructured":"Hong, L. et al. The disulfidptosis-related lncRNAs can predict survival and immunotherapy response accurately in endometrial carcinoma. Cell. Mol. Biol. 71, 20\u201330 (2025).","journal-title":"Cell. Mol. Biol."},{"key":"3001_CR189","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1007\/s12672-024-01664-z","volume":"15","author":"J Wang","year":"2024","unstructured":"Wang, J. et al. Development and validation of disulfidptosis-related genes signature for patients with glioma. Discov. Oncol. 15, 758 (2024).","journal-title":"Discov. Oncol."},{"key":"3001_CR190","doi-asserted-by":"publisher","first-page":"115657","DOI":"10.1016\/j.isci.2026.115657","volume":"29","author":"R Huang","year":"2026","unstructured":"Huang, R. et al. Integration of machine learning to develop a disulfidptosis model for predicting glioma prognosis, immunotherapy response, and drug. iScience 29, 115657 (2026).","journal-title":"iScience"},{"key":"3001_CR191","doi-asserted-by":"publisher","first-page":"20230825","DOI":"10.1515\/med-2023-0825","volume":"18","author":"XM Li","year":"2023","unstructured":"Li, X. M. et al. Identification of disulfidptosis-related genes and immune infiltration in lower-grade glioma. Open Med. 18, 20230825 (2023).","journal-title":"Open Med."},{"key":"3001_CR192","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s12031-024-02216-4","volume":"74","author":"Y Zhuang","year":"2024","unstructured":"Zhuang, Y., Chen, J., Mai, Z., Huang, W. & Zhong, W. Signature construction and disulfidptosis-related molecular cluster identification for better prediction of prognosis in glioma. J. Mol. Neurosci. 74, 38 (2024).","journal-title":"J. Mol. Neurosci."},{"key":"3001_CR193","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s00432-025-06159-0","volume":"151","author":"C Chen","year":"2025","unstructured":"Chen, C. et al. Developing and validating a prognostic disulfidptosis-related signature for glioblastoma: predicting radioresistance and synergestic effect with immunotherapy. J. Cancer Res. Clin. Oncol. 151, 112 (2025).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"3001_CR194","doi-asserted-by":"publisher","first-page":"1526296","DOI":"10.3389\/fimmu.2025.1526296","volume":"16","author":"Y Shu","year":"2025","unstructured":"Shu, Y. & Li, J. Disulfidptosis as a key regulator of glioblastoma progression and immune cell impairment. Front. Immunol. 16, 1526296 (2025).","journal-title":"Front. Immunol."},{"key":"3001_CR195","doi-asserted-by":"publisher","first-page":"1025286","DOI":"10.3389\/fimmu.2022.1025286","volume":"13","author":"M Han","year":"2022","unstructured":"Han, M. et al. Comprehensive characterization of TNFSF14\/LIGHT with implications in prognosis and immunotherapy of human gliomas. Front. Immunol. 13, 1025286 (2022).","journal-title":"Front. Immunol."},{"key":"3001_CR196","first-page":"101605","volume":"37","author":"Q Jiang","year":"2024","unstructured":"Jiang, Q. et al. Identification of prognostic risk score of disulfidptosis-related genes and molecular subtypes in glioma. Biochem. Biophys. Rep. 37, 101605 (2024).","journal-title":"Biochem. Biophys. Rep."},{"key":"3001_CR197","doi-asserted-by":"publisher","first-page":"5573323","DOI":"10.1155\/ijog\/5573323","volume":"2025","author":"T Li","year":"2025","unstructured":"Li, T. et al. A novel signature of disulfidptosis-related lncRNAs predicts prognosis in glioma: evidence from bioinformatic analysis and experiments. Int. J. Genom. 2025, 5573323 (2025).","journal-title":"Int. J. Genom."},{"key":"3001_CR198","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-025-00748-4","volume":"13","author":"F Du","year":"2025","unstructured":"Du, F. et al. Targeting novel regulated cell death: disulfidptosis in cancer immunotherapy with immune checkpoint inhibitors. Biomark. Res. 13, 35 (2025).","journal-title":"Biomark. Res."},{"key":"3001_CR199","doi-asserted-by":"publisher","first-page":"101849","DOI":"10.1016\/j.smim.2023.101849","volume":"70","author":"L Dejas","year":"2023","unstructured":"Dejas, L., Santoni, K., Meunier, E. & Lamkanfi, M. Regulated cell death in neutrophils: from apoptosis to NETosis and pyroptosis. Semin. Immunol. 70, 101849 (2023).","journal-title":"Semin. Immunol."},{"key":"3001_CR200","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.24272\/j.issn.2095-8137.2023.294","volume":"44","author":"XW Zhang","year":"2023","unstructured":"Zhang, X. W., Zhu, X. X., Tang, D. S. & Lu, J. H. Targeting autophagy in Alzheimer\u2019s disease: animal models and mechanisms. Zool. Res. 44, 1132\u20131145 (2023).","journal-title":"Zool. Res."},{"key":"3001_CR201","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.3390\/ijms24021059","volume":"24","author":"BK Beata","year":"2023","unstructured":"Beata, B. K., Wojciech, J., Johannes, K., Piotr, L. & Barbara, M. Alzheimer\u2019s disease-biochemical and psychological background for diagnosis and treatment. Int. J. Mol. Sci. 24, 1059 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"3001_CR202","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens, P. et al. Alzheimer\u2019s disease. Lancet 397, 1577\u20131590 (2021).","journal-title":"Lancet"},{"key":"3001_CR203","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3390\/ijms24010107","volume":"24","author":"AA Rostagno","year":"2022","unstructured":"Rostagno, A. A. Pathogenesis of Alzheimer\u2019s disease. Int. J. Mol. Sci. 24, 107 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"3001_CR204","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/26506","volume":"395","author":"N Mizushima","year":"1998","unstructured":"Mizushima, N. et al. A protein conjugation system essential for autophagy. Nature 395, 395\u2013398 (1998).","journal-title":"Nature"},{"key":"3001_CR205","doi-asserted-by":"publisher","first-page":"908","DOI":"10.3390\/ijms21030908","volume":"21","author":"S Pelucchi","year":"2020","unstructured":"Pelucchi, S., Stringhi, R. & Marcello, E. Dendritic spines in Alzheimer\u2019s disease: how the actin cytoskeleton contributes to synaptic failure. Int. J. Mol. Sci. 21, 908 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"3001_CR206","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1083\/jcb.200111026","volume":"157","author":"Y Ward","year":"2002","unstructured":"Ward, Y. et al. The GTP binding proteins Gem and Rad are negative regulators of the Rho-Rho kinase pathway. J. Cell Biol. 157, 291\u2013302 (2002).","journal-title":"J. Cell Biol."},{"key":"3001_CR207","doi-asserted-by":"publisher","first-page":"e00034","DOI":"10.1042\/AN20100005","volume":"2","author":"M Uittenbogaard","year":"2010","unstructured":"Uittenbogaard, M., Baxter, K. K. & Chiaramello, A. The neurogenic basic helix-loop-helix transcription factor NeuroD6 confers tolerance to oxidative stress by triggering an antioxidant response and sustaining the mitochondrial biomass. ASN Neuro 2, e00034 (2010).","journal-title":"ASN Neuro"},{"key":"3001_CR208","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.jalz.2015.07.487","volume":"11","author":"S Barral","year":"2015","unstructured":"Barral, S. et al. Linkage analyses in Caribbean Hispanic families identify novel loci associated with familial late-onset Alzheimer\u2019s disease. Alzheimers Dement 11, 1397\u20131406 (2015).","journal-title":"Alzheimers Dement"},{"key":"3001_CR209","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1093\/hmg\/6.7.1137","volume":"6","author":"E Montini","year":"1997","unstructured":"Montini, E. et al. A novel human serine-threonine phosphatase related to the Drosophila retinal degeneration C (rdgC) gene is selectively expressed in sensory neurons of neural crest origin. Hum. Mol. Genet. 6, 1137\u20131145 (1997).","journal-title":"Hum. Mol. Genet."},{"key":"3001_CR210","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0196-9781(02)00290-5","volume":"24","author":"TW Moody","year":"2003","unstructured":"Moody, T. W., Hill, J. M. & Jensen, R. T. VIP as a trophic factor in the CNS and cancer cells. Peptides 24, 163\u2013177 (2003).","journal-title":"Peptides"},{"key":"3001_CR211","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3389\/fnmol.2017.00203","volume":"10","author":"X Xu","year":"2017","unstructured":"Xu, X. et al. Nupr1 modulates methamphetamine-induced dopaminergic neuronal apoptosis and autophagy through CHOP-Trib3-mediated endoplasmic reticulum stress signaling pathway. Front. Mol. Neurosci. 10, 203 (2017).","journal-title":"Front. Mol. Neurosci."},{"key":"3001_CR212","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3892\/ijo.2021.5201","volume":"58","author":"TA Martin","year":"2021","unstructured":"Martin, T. A. et al. NUPR1 and its potential role in cancer and pathological conditions (Review). Int. J. Oncol. 58, 21 (2021).","journal-title":"Int. J. Oncol."},{"key":"3001_CR213","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.1037","volume":"11","author":"Y Zhu","year":"2023","unstructured":"Zhu, Y., Kong, L., Han, T., Yan, Q. & Liu, J. Machine learning identification and immune infiltration of disulfidptosis-related Alzheimer\u2019s disease molecular subtypes. Immun. Inflamm. Dis. 11, e1037 (2023).","journal-title":"Immun. Inflamm. Dis."},{"key":"3001_CR214","doi-asserted-by":"publisher","first-page":"10038","DOI":"10.3390\/cimb46090600","volume":"46","author":"T Liu","year":"2024","unstructured":"Liu, T., Kong, X. & Wei, J. Disulfidptosis: a new target for Parkinson\u2019s disease and cancer. Curr. Issues Mol. Biol. 46, 10038\u201310064 (2024).","journal-title":"Curr. Issues Mol. Biol."},{"key":"3001_CR215","doi-asserted-by":"publisher","first-page":"1236490","DOI":"10.3389\/fnagi.2023.1236490","volume":"15","author":"S Ma","year":"2023","unstructured":"Ma, S., Wang, D. & Xie, D. Identification of disulfidptosis-related genes and subgroups in Alzheimer\u2019s disease. Front. Aging Neurosci. 15, 1236490 (2023).","journal-title":"Front. Aging Neurosci."},{"key":"3001_CR216","doi-asserted-by":"publisher","first-page":"1514253","DOI":"10.3389\/fnins.2025.1514253","volume":"19","author":"J Chang","year":"2025","unstructured":"Chang, J. et al. Disulfidptosis: a new target for central nervous system disease therapy. Front. Neurosci. 19, 1514253 (2025).","journal-title":"Front. Neurosci."},{"key":"3001_CR217","doi-asserted-by":"publisher","first-page":"1513342","DOI":"10.3389\/fcvm.2025.1513342","volume":"12","author":"L Chen","year":"2025","unstructured":"Chen, L., Wei, J., Deng, G. & Xu, G. Disulfidptosis-related gene in acute myocardial infarction and its diagnostic value and functions based on bioinformatics analysis and machine learning. Front. Cardiovasc. Med. 12, 1513342 (2025).","journal-title":"Front. Cardiovasc. Med."},{"key":"3001_CR218","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1038\/s41591-019-0512-5","volume":"25","author":"RC Wirka","year":"2019","unstructured":"Wirka, R. C. et al. Atheroprotective roles of smooth muscle cell phenotypic modulation and the TCF21 disease gene as revealed by single-cell analysis. Nat. Med. 25, 1280\u20131289 (2019).","journal-title":"Nat. Med."},{"key":"3001_CR219","doi-asserted-by":"publisher","first-page":"H893","DOI":"10.1152\/ajpheart.00142.2021","volume":"321","author":"KA Liao","year":"2021","unstructured":"Liao, K. A., Rangarajan, K. V., Bai, X., Taylor, J. M. & Mack, C. P. The actin depolymerizing factor destrin serves as a negative feedback inhibitor of smooth muscle cell differentiation. Am. J. Physiol. Heart Circ. Physiol. 321, H893\u2013H904 (2021).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"3001_CR220","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1194\/jlr.M082651","volume":"59","author":"FH Gong","year":"2018","unstructured":"Gong, F. H. et al. Reduced atherosclerosis lesion size, inflammatory response in miR-150 knockout mice via macrophage effects. J. Lipid Res. 59, 658\u2013669 (2018).","journal-title":"J. Lipid Res."},{"key":"3001_CR221","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s13075-022-02974-9","volume":"24","author":"M Yoshinari","year":"2022","unstructured":"Yoshinari, M. et al. Low disease activity of microscopic polyangiitis in patients with anti-myosin light chain 6 antibody that disrupts actin rearrangement necessary for neutrophil extracellular trap formation. Arthritis Res. Ther. 24, 274 (2022).","journal-title":"Arthritis Res. Ther."},{"key":"3001_CR222","doi-asserted-by":"publisher","first-page":"4993","DOI":"10.7150\/thno.87968","volume":"13","author":"P Xiang","year":"2023","unstructured":"Xiang, P. et al. Metabolite Neu5Ac triggers SLC3A2 degradation promoting vascular endothelial ferroptosis and aggravates atherosclerosis progression in ApoE(-\/-)mice. Theranostics 13, 4993\u20135016 (2023).","journal-title":"Theranostics"},{"key":"3001_CR223","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/cvr\/cvu226","volume":"105","author":"S Bandaru","year":"2015","unstructured":"Bandaru, S. et al. Deficiency of filamin A in endothelial cells impairs left ventricular remodelling after myocardial infarction. Cardiovasc. Res. 105, 151\u2013159 (2015).","journal-title":"Cardiovasc. Res."},{"key":"3001_CR224","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1161\/CIRCULATIONAHA.119.039697","volume":"140","author":"S Bandaru","year":"2019","unstructured":"Bandaru, S. et al. Targeting Filamin A reduces macrophage activity and atherosclerosis. Circulation 140, 67\u201379 (2019).","journal-title":"Circulation"},{"key":"3001_CR225","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s10020-024-01024-1","volume":"30","author":"H Fan","year":"2024","unstructured":"Fan, H. et al. Identification and validation of differentially expressed disulfidptosis-related genes in hypertrophic cardiomyopathy. Mol. Med. 30, 249 (2024).","journal-title":"Mol. Med."},{"key":"3001_CR226","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41586-022-04817-8","volume":"608","author":"M Chaffin","year":"2022","unstructured":"Chaffin, M. et al. Single-nucleus profiling of human dilated and hypertrophic cardiomyopathy. Nature 608, 174\u2013180 (2022).","journal-title":"Nature"},{"key":"3001_CR227","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","volume":"121","author":"AJ Marian","year":"2017","unstructured":"Marian, A. J. & Braunwald, E. Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy. Circ. Res. 121, 749\u2013770 (2017).","journal-title":"Circ. Res."},{"key":"3001_CR228","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1152\/physiolgenomics.00048.2018","volume":"50","author":"J Xue","year":"2018","unstructured":"Xue, J. et al. Exploring miRNA\u2012mRNA regulatory network in cardiac pathology in Na(+)\/H(+) exchanger isoform 1 transgenic mice. Physiol. Genom. 50, 846\u2013861 (2018).","journal-title":"Physiol. Genom."},{"key":"3001_CR229","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3001447","volume":"19","author":"AM Santamans","year":"2021","unstructured":"Santamans, A. M. et al. p38\u03b3 and p38\u03b4 regulate postnatal cardiac metabolism through glycogen synthase 1. PLoS Biol. 19, e3001447 (2021).","journal-title":"PLoS Biol."},{"key":"3001_CR230","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41569-020-0428-2","volume":"18","author":"WJ McKenna","year":"2021","unstructured":"McKenna, W. J. & Judge, D. P. Epidemiology of the inherited cardiomyopathies. Nat. Rev. Cardiol. 18, 22\u201336 (2021).","journal-title":"Nat. Rev. Cardiol."},{"key":"3001_CR231","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1186\/s12931-024-02978-w","volume":"25","author":"X Tan","year":"2024","unstructured":"Tan, X. et al. Exploring the diagnostic and immune infiltration roles of disulfidptosis related genes in pulmonary hypertension. Respir. Res. 25, 365 (2024).","journal-title":"Respir. Res."},{"key":"3001_CR232","doi-asserted-by":"publisher","first-page":"19619","DOI":"10.1073\/pnas.1908706116","volume":"116","author":"PC Wilson","year":"2019","unstructured":"Wilson, P. C. et al. The single-cell transcriptomic landscape of early human diabetic nephropathy. Proc. Natl. Acad. Sci. USA 116, 19619\u201319625 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"3001_CR233","doi-asserted-by":"publisher","first-page":"1287613","DOI":"10.3389\/fgene.2023.1287613","volume":"14","author":"D Xu","year":"2023","unstructured":"Xu, D., Jiang, C., Xiao, Y. & Ding, H. Identification and validation of disulfidptosis-related gene signatures and their subtype in diabetic nephropathy. Front. Genet 14, 1287613 (2023).","journal-title":"Front. Genet"},{"key":"3001_CR234","doi-asserted-by":"publisher","first-page":"791","DOI":"10.2337\/db16-0796","volume":"66","author":"RE Gilbert","year":"2017","unstructured":"Gilbert, R. E. Proximal tubulopathy: prime mover and key therapeutic target in diabetic kidney disease. Diabetes 66, 791\u2013800 (2017).","journal-title":"Diabetes"},{"key":"3001_CR235","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.arcmed.2020.08.005","volume":"52","author":"SZ Wang","year":"2021","unstructured":"Wang, S. Z., Zhang, Y. L. & Shi, H. B. Potential repressive impact of microRNA-20a on renal tubular damage in diabetic kidney disease by targeting C-X-C motif chemokine ligand 6. Arch. Med. Res. 52, 58\u201368 (2021).","journal-title":"Arch. Med. Res."},{"key":"3001_CR236","first-page":"5546199","volume":"2021","author":"B Xu","year":"2021","unstructured":"Xu, B. et al. Investigation of the mechanism of complement system in diabetic nephropathy via bioinformatics analysis. J. Diab. Res. 2021, 5546199 (2021).","journal-title":"J. Diab. Res."},{"key":"3001_CR237","doi-asserted-by":"publisher","first-page":"932205","DOI":"10.3389\/fphar.2022.932205","volume":"13","author":"H Cao","year":"2022","unstructured":"Cao, H., Rao, X., Jia, J., Yan, T. & Li, D. Exploring the pathogenesis of diabetic kidney disease by microarray data analysis. Front. Pharmacol. 13, 932205 (2022).","journal-title":"Front. Pharmacol."},{"key":"3001_CR238","doi-asserted-by":"publisher","first-page":"1128136","DOI":"10.3389\/fgene.2023.1128136","volume":"14","author":"B Li","year":"2023","unstructured":"Li, B., Zhao, X., Xie, W., Hong, Z. & Zhang, Y. Integrative analyses of biomarkers and pathways for diabetic nephropathy. Front. Genet. 14, 1128136 (2023).","journal-title":"Front. Genet."},{"key":"3001_CR239","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1097\/01.ASN.0000065640.77499.D7","volume":"14","author":"RM Mason","year":"2003","unstructured":"Mason, R. M. & Wahab, N. A. Extracellular matrix metabolism in diabetic nephropathy. J. Am. Soc. Nephrol. 14, 1358\u20131373 (2003).","journal-title":"J. Am. Soc. Nephrol."},{"key":"3001_CR240","doi-asserted-by":"publisher","first-page":"20251273","DOI":"10.1515\/biol-2025-1273","volume":"21","author":"M Tan","year":"2026","unstructured":"Tan, M. et al. Heterogeneity characterization and key pathogenic genes screening based on diabetic nephropathy microenvironment. Open Life Sci. 21, 20251273 (2026).","journal-title":"Open Life Sci."},{"key":"3001_CR241","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00592-022-02027-2","volume":"60","author":"H Gui","year":"2023","unstructured":"Gui, H., Chen, X., Ye, L. & Ma, H. Seven basement membrane-specific expressed genes are considered potential biomarkers for the diagnosis and treatment of diabetic nephropathy. Acta Diabetol. 60, 493\u2013505 (2023).","journal-title":"Acta Diabetol."},{"key":"3001_CR242","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.2147\/JIR.S458951","volume":"17","author":"M Fu","year":"2024","unstructured":"Fu, M. et al. Identification of key disulfidptosis-related genes and their association with gene expression subtypes in Crohn\u2019s disease. J. Inflamm. Res. 17, 3655\u20133670 (2024).","journal-title":"J. Inflamm. Res."},{"key":"3001_CR243","doi-asserted-by":"publisher","first-page":"1326354","DOI":"10.3389\/fimmu.2024.1326354","volume":"15","author":"L Li","year":"2024","unstructured":"Li, L. et al. Regulation mechanisms of disulfidptosis-related genes in ankylosing spondylitis and inflammatory bowel disease. Front. Immunol. 15, 1326354 (2024).","journal-title":"Front. Immunol."},{"key":"3001_CR244","doi-asserted-by":"crossref","unstructured":"Foell, D. et al. Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis. Rheumatology 42, 1383\u20131389 (2003).","DOI":"10.1093\/rheumatology\/keg385"},{"key":"3001_CR245","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1002\/art.20125","volume":"50","author":"D Foell","year":"2004","unstructured":"Foell, D. et al. Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations. Arthritis Rheum. 50, 1286\u20131295 (2004).","journal-title":"Arthritis Rheum."},{"key":"3001_CR246","doi-asserted-by":"publisher","first-page":"5349837","DOI":"10.1155\/2018\/5349837","volume":"2018","author":"K Orczyk","year":"2018","unstructured":"Orczyk, K. & Smolewska, E. A granulocyte-specific protein S100A12 as a potential prognostic factor affecting aggressiveness of therapy in patients with juvenile idiopathic arthritis. J. Immunol. Res 2018, 5349837 (2018).","journal-title":"J. Immunol. Res"},{"key":"3001_CR247","doi-asserted-by":"publisher","first-page":"3924","DOI":"10.1002\/art.24137","volume":"58","author":"H Wittkowski","year":"2008","unstructured":"Wittkowski, H. et al. S100A12 is a novel molecular marker differentiating systemic-onset juvenile idiopathic arthritis from other causes of fever of unknown origin. Arthritis Rheum. 58, 3924\u20133931 (2008).","journal-title":"Arthritis Rheum."},{"key":"3001_CR248","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e34516","volume":"10","author":"L Yang","year":"2024","unstructured":"Yang, L., Yuan, L. & Liu, G. Comprehensive evaluation of disulfidptosis in intestinal immunity and biologic therapy response in Ulcerative Colitis. Heliyon 10, e34516 (2024).","journal-title":"Heliyon"},{"key":"3001_CR249","doi-asserted-by":"publisher","first-page":"13506","DOI":"10.3390\/ijms252413506","volume":"25","author":"QQ Yang","year":"2024","unstructured":"Yang, Q. Q. et al. Disulfidptosis and its hub gene Slc3a2 involved in ulcerative colitis pathogenesis, disease progression, and patient responses to biologic therapies. Int. J. Mol. Sci. 25, 13506 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"3001_CR250","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1111\/j.1440-1681.2009.05242.x","volume":"36","author":"L Boiss\u00e9","year":"2009","unstructured":"Boiss\u00e9, L., Chisholm, S. P., Lukewich, M. K. & Lomax, A. E. Clinical and experimental evidence of sympathetic neural dysfunction during inflammatory bowel disease. Clin. Exp. Pharmacol. Physiol. 36, 1026\u20131033 (2009).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"3001_CR251","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17344-9","volume":"11","author":"MP Neuser","year":"2020","unstructured":"Neuser, M. P. et al. Vagus nerve stimulation boosts the drive to work for rewards. Nat. Commun. 11, 3555 (2020).","journal-title":"Nat. Commun."},{"key":"3001_CR252","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39401-9","volume":"14","author":"Y Yan","year":"2023","unstructured":"Yan, Y. et al. SLC7A11 expression level dictates differential responses to oxidative stress in cancer cells. Nat. Commun. 14, 3673 (2023).","journal-title":"Nat. Commun."},{"key":"3001_CR253","doi-asserted-by":"publisher","first-page":"5142","DOI":"10.7150\/ijbs.133562","volume":"22","author":"L Yang","year":"2026","unstructured":"Yang, L. et al. A context-dependent METTL1-m7G-SLC7A11 axis links metabolic stress to epithelial fate in ulcerative colitis. Int. J. Biol. Sci. 22, 5142\u20135160 (2026).","journal-title":"Int. J. Biol. Sci."},{"key":"3001_CR254","doi-asserted-by":"publisher","first-page":"118527","DOI":"10.1016\/j.jep.2024.118527","volume":"334","author":"J Huang","year":"2024","unstructured":"Huang, J., Zhang, J., Wang, F. & Tang, X. Exploring the immune landscape of disulfidptosis in ulcerative colitis and the role of modified gegen qinlian decoction in mediating disulfidptosis to alleviate colitis in mice. J. Ethnopharmacol. 334, 118527 (2024).","journal-title":"J. Ethnopharmacol."},{"key":"3001_CR255","doi-asserted-by":"publisher","first-page":"111605","DOI":"10.1016\/j.intimp.2024.111605","volume":"129","author":"Q Wang","year":"2024","unstructured":"Wang, Q., Xiao, Z., Hou, Z. & Li, D. Effect of disulfidptosis-related genes SLC3A2, SLC7A11 and FLNB polymorphisms on risk of autoimmune thyroiditis in a Chinese population. Int. Immunopharmacol. 129, 111605 (2024).","journal-title":"Int. Immunopharmacol."},{"key":"3001_CR256","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41572-024-00565-3","volume":"10","author":"RB Singh","year":"2024","unstructured":"Singh, R. B. et al. Keratoconus. Nat. Rev. Dis. Prim. 10, 81 (2024).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"3001_CR257","doi-asserted-by":"publisher","first-page":"44","DOI":"10.51329\/mehdiophthal1493","volume":"13","author":"N Alqudah","year":"2024","unstructured":"Alqudah, N. Keratoconus: imaging modalities and management. Med. Hypothesis Discov. Innov. Ophthalmol. 13, 44\u201354 (2024).","journal-title":"Med. Hypothesis Discov. Innov. Ophthalmol."},{"key":"3001_CR258","doi-asserted-by":"publisher","first-page":"101559","DOI":"10.1016\/j.clae.2021.101559","volume":"45","author":"J Santodomingo-Rubido","year":"2022","unstructured":"Santodomingo-Rubido, J. et al. Keratoconus: an updated review. Cont. Lens Anterior Eye 45, 101559 (2022).","journal-title":"Cont. Lens Anterior Eye"},{"key":"3001_CR259","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/ICO.0000000000003585","volume":"44","author":"R Vought","year":"2025","unstructured":"Vought, R., Greenstein, S. A., Gelles, J. & Hersh, P. S. The pathophysiology of keratoconus. Cornea 44, 137\u2013143 (2025).","journal-title":"Cornea"},{"key":"3001_CR260","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41421-022-00397-z","volume":"8","author":"S Dou","year":"2022","unstructured":"Dou, S. et al. Single-cell atlas of keratoconus corneas revealed aberrant transcriptional signatures and implicated mechanical stretch as a trigger for keratoconus pathogenesis. Cell Discov. 8, 66 (2022).","journal-title":"Cell Discov."},{"key":"3001_CR261","doi-asserted-by":"publisher","first-page":"100143","DOI":"10.1016\/j.imj.2024.100143","volume":"3","author":"W Zou","year":"2024","unstructured":"Zou, W., Sai, L., Sai, W., Song, L. & Wang, G. Diagnostic and prognostic value of disulfidptosis-related genes in sepsis. Infect. Med. 3, 100143 (2024).","journal-title":"Infect. Med."},{"key":"3001_CR262","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41568-021-00378-6","volume":"21","author":"I Mart\u00ednez-Reyes","year":"2021","unstructured":"Mart\u00ednez-Reyes, I. & Chandel, N. S. Cancer metabolism: looking forward. Nat. Rev. Cancer 21, 669\u2013680 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"3001_CR263","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1093\/ecco-jcc\/jjaa236","volume":"15","author":"JJ Ashton","year":"2021","unstructured":"Ashton, J. J. et al. Ileal transcriptomic analysis in paediatric Crohn\u2019s disease reveals IL17- and NOD-signalling expression signatures in treatment-na\u00efve patients and identifies epithelial cells driving differentially expressed genes. J. Crohns Colitis 15, 774\u2013786 (2021).","journal-title":"J. Crohns Colitis"},{"key":"3001_CR264","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s41589-020-0533-x","volume":"16","author":"JM Ghergurovich","year":"2020","unstructured":"Ghergurovich, J. M. et al. A small molecule G6PD inhibitor reveals immune dependence on pentose phosphate pathway. Nat. Chem. Biol. 16, 731\u2013739 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"3001_CR265","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1007\/s10637-011-9739-9","volume":"30","author":"RK Ramanathan","year":"2012","unstructured":"Ramanathan, R. K. et al. A phase I trial of PX-12, a small-molecule inhibitor of thioredoxin-1, administered as a 72-hour infusion every 21 days in patients with advanced cancers refractory to standard therapy. Invest. N. Drugs 30, 1591\u20131596 (2012).","journal-title":"Invest. N. Drugs"},{"key":"3001_CR266","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/sj.bjp.0707342","volume":"151","author":"A Mukherjee","year":"2007","unstructured":"Mukherjee, A., Huber, K., Evans, H., Lakhani, N. & Martin, S. A cellular and molecular investigation of the action of PMX464, a putative thioredoxin inhibitor, in normal and colorectal cancer cell lines. Br. J. Pharmacol. 151, 1167\u20131175 (2007).","journal-title":"Br. J. Pharmacol."},{"key":"3001_CR267","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.132","volume":"5","author":"C Fan","year":"2014","unstructured":"Fan, C. et al. Enhancement of auranofin-induced lung cancer cell apoptosis by selenocystine, a natural inhibitor of TrxR1 in vitro and in vivo. Cell Death Dis. 5, e1191 (2014).","journal-title":"Cell Death Dis."},{"key":"3001_CR268","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05586-6","volume":"14","author":"MJ Seo","year":"2023","unstructured":"Seo, M. J. et al. Dual inhibition of thioredoxin reductase and proteasome is required for auranofin-induced paraptosis in breast cancer cells. Cell Death Dis. 14, 42 (2023).","journal-title":"Cell Death Dis."},{"key":"3001_CR269","doi-asserted-by":"publisher","first-page":"249","DOI":"10.7150\/ijbs.86160","volume":"20","author":"P Zheng","year":"2024","unstructured":"Zheng, P. et al. Combination of TrxR1 inhibitor and lenvatinib triggers ROS-dependent cell death in human lung cancer cells. Int. J. Biol. Sci. 20, 249\u2013264 (2024).","journal-title":"Int. J. Biol. Sci."},{"key":"3001_CR270","doi-asserted-by":"publisher","first-page":"2162807","DOI":"10.1080\/15384047.2022.2162807","volume":"24","author":"M Chen","year":"2023","unstructured":"Chen, M. et al. Curcumin analog WZ26 induces ROS and cell death via inhibition of STAT3 in cholangiocarcinoma. Cancer Biol. Ther. 24, 2162807 (2023).","journal-title":"Cancer Biol. Ther."},{"key":"3001_CR271","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.freeradbiomed.2019.06.005","volume":"141","author":"T Zhang","year":"2019","unstructured":"Zhang, T. et al. Curcuminoid WZ26, a TrxR1 inhibitor, effectively inhibits colon cancer cell growth and enhances cisplatin-induced cell death through the induction of ROS. Free Radic. Biol. Med. 141, 93\u2013102 (2019).","journal-title":"Free Radic. Biol. Med."},{"key":"3001_CR272","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s41418-024-01440-0","volume":"32","author":"M Tang","year":"2025","unstructured":"Tang, M. et al. Inhibition of thioredoxin reductase 1 sensitizes glucose-starved glioblastoma cells to disulfidptosis. Cell Death Differ. 32, 598\u2013612 (2025).","journal-title":"Cell Death Differ."},{"key":"3001_CR273","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1038\/s44318-024-00117-1","volume":"43","author":"P Mart\u00ed-Andr\u00e9s","year":"2024","unstructured":"Mart\u00ed-Andr\u00e9s, P. et al. TRP14 is the rate-limiting enzyme for intracellular cystine reduction and regulates proteome cysteinylation. EMBO J. 43, 2789\u20132812 (2024).","journal-title":"EMBO J."},{"key":"3001_CR274","doi-asserted-by":"publisher","first-page":"6964","DOI":"10.1073\/pnas.1317320111","volume":"111","author":"I Pader","year":"2014","unstructured":"Pader, I. et al. Thioredoxin-related protein of 14 kDa is an efficient L-cystine reductase and S-denitrosylase. Proc. Natl. Acad. Sci. USA 111, 6964\u20136969 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"3001_CR275","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj3460001","volume":"346","author":"D Mustacich","year":"2000","unstructured":"Mustacich, D. & Powis, G. Thioredoxin reductase. Biochem. J. 346, 1\u20138 (2000).","journal-title":"Biochem. J."},{"key":"3001_CR276","doi-asserted-by":"publisher","first-page":"6102","DOI":"10.1046\/j.1432-1327.2000.01701.x","volume":"267","author":"ES Arn\u00e9r","year":"2000","unstructured":"Arn\u00e9r, E. S. & Holmgren, A. Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem. 267, 6102\u20136109 (2000).","journal-title":"Eur. J. Biochem."},{"key":"3001_CR277","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.semcancer.2006.10.009","volume":"16","author":"ES Arn\u00e9r","year":"2006","unstructured":"Arn\u00e9r, E. S. & Holmgren, A. The thioredoxin system in cancer. Semin. Cancer Biol. 16, 420\u2013426 (2006).","journal-title":"Semin. Cancer Biol."},{"key":"3001_CR278","doi-asserted-by":"publisher","first-page":"e01947","DOI":"10.1128\/AAC.01947-16","volume":"61","author":"EV Capparelli","year":"2017","unstructured":"Capparelli, E. V., Bricker-Ford, R., Rogers, M. J., McKerrow, J. H. & Reed, S. L. Phase I clinical trial results of auranofin, a novel antiparasitic agent. Antimicrob. Agents Chemother. 61, e01947\u201316 (2017).","journal-title":"Antimicrob. Agents Chemother."},{"key":"3001_CR279","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-62634-9","volume":"16","author":"Y Wang","year":"2025","unstructured":"Wang, Y. et al. Ligand supplementation restores the cancer therapy efficacy of the antirheumatic drug auranofin from serum inactivation. Nat. Commun. 16, 7347 (2025).","journal-title":"Nat. Commun."},{"key":"3001_CR280","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202411131","volume":"12","author":"M Shi","year":"2025","unstructured":"Shi, M. et al. Gaudichaudione H enhances the sensitivity of hepatocellular carcinoma cells to disulfidptosis via regulating NRF2-SLC7A11 signaling pathway. Adv. Sci. 12, e2411131 (2025).","journal-title":"Adv. Sci."},{"key":"3001_CR281","doi-asserted-by":"publisher","first-page":"e202310153","DOI":"10.1083\/jcb.202310153","volume":"223","author":"M R\u00f6tte","year":"2024","unstructured":"R\u00f6tte, M. et al. CYRI controls epidermal wound closure and cohesion of invasive border cell cluster in Drosophila. J. Cell Biol. 223, e202310153 (2024).","journal-title":"J. Cell Biol."},{"key":"3001_CR282","doi-asserted-by":"publisher","first-page":"30303","DOI":"10.1021\/acsnano.5c08432","volume":"19","author":"Y Xu","year":"2025","unstructured":"Xu, Y. et al. Disulfidptosis nanoinducer interrupts tumor metabolic privilege to boost sustained immunotherapy. ACS Nano 19, 30303\u201330321 (2025).","journal-title":"ACS Nano"},{"key":"3001_CR283","doi-asserted-by":"publisher","first-page":"123359","DOI":"10.1016\/j.biomaterials.2025.123359","volume":"322","author":"K Zhang","year":"2025","unstructured":"Zhang, K. et al. Manganese-based nanoadjuvants for the synergistic enhancement of immune responses in breast cancer therapy via disulfidptosis-induced ICD and cGAS-STING activation. Biomaterials 322, 123359 (2025).","journal-title":"Biomaterials"},{"key":"3001_CR284","doi-asserted-by":"publisher","first-page":"123178","DOI":"10.1016\/j.biomaterials.2025.123178","volume":"319","author":"K Wang","year":"2025","unstructured":"Wang, K. et al. Sonodynamic activated nanoparticles with Glut1 inhibitor and cystine-containing polymer stimulate disulfidptosis for improved immunotherapy in bladder cancer. Biomaterials 319, 123178 (2025).","journal-title":"Biomaterials"},{"key":"3001_CR285","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3003284","volume":"23","author":"Y Qiu","year":"2025","unstructured":"Qiu, Y. et al. Bi-directional metabolic reprogramming between cancer cells and T cells reshapes the anti-tumor immune response. PLoS Biol. 23, e3003284 (2025).","journal-title":"PLoS Biol."},{"key":"3001_CR286","doi-asserted-by":"publisher","first-page":"4747","DOI":"10.1007\/s00210-024-03623-5","volume":"398","author":"AC Famurewa","year":"2025","unstructured":"Famurewa, A. C. et al. Mechanisms of ferroptotic and non-ferroptotic organ toxicity of chemotherapy: protective and therapeutic effects of ginger, 6-gingerol and zingerone in preclinical studies. Naunyn Schmied. Arch. Pharmacol. 398, 4747\u20134778 (2025).","journal-title":"Naunyn Schmied. Arch. Pharmacol."},{"key":"3001_CR287","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1182\/blood.V96.1.307","volume":"96","author":"E Shacter","year":"2000","unstructured":"Shacter, E., Williams, J. A., Hinson, R. M., Sent\u00fcrker, S. & Lee, Y. J. Oxidative stress interferes with cancer chemotherapy: inhibition of lymphoma cell apoptosis poptosis and phagocytosis. Blood 96, 307\u2013313 (2000).","journal-title":"Blood"},{"key":"3001_CR288","doi-asserted-by":"publisher","first-page":"170749","DOI":"10.1016\/j.cej.2025.170749","volume":"526","author":"J Ruan","year":"2025","unstructured":"Ruan, J. et al. NADPH oxidase-mimicking nanozyme for disulfidptosis-induction strategy to amplify cuproptosis in cancer therapy. Chem. Eng. J. 526, 170749 (2025).","journal-title":"Chem. Eng. J."},{"key":"3001_CR289","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s00424-020-02441-x","volume":"472","author":"H Koepsell","year":"2020","unstructured":"Koepsell, H. Glucose transporters in brain in health and disease. Pflug. Arch. 472, 1299\u20131343 (2020).","journal-title":"Pflug. Arch."},{"key":"3001_CR290","first-page":"281","volume":"17","author":"A D\u2019Alessandro","year":"2019","unstructured":"D\u2019Alessandro, A., Hansen, K. C., Eisenmesser, E. Z. & Zimring, J. C. Protect, repair, destroy or sacrifice: a role of oxidative stress biology in inter-donor variability of blood storage? Blood Transfus. 17, 281\u2013288 (2019).","journal-title":"Blood Transfus."},{"key":"3001_CR291","doi-asserted-by":"publisher","first-page":"e31609","DOI":"10.1002\/pbc.31609","volume":"72","author":"GP Prashanth","year":"2025","unstructured":"Prashanth, G. P., Al-Shafey, M., Tandon, A. & Ismail, S. Fava bean- versus non-Fava bean-induced acute hemolytic crisis in children with glucose-6-phosphate dehydrogenase deficiency: a prospective comparative study. Pediatr. Blood Cancer 72, e31609 (2025).","journal-title":"Pediatr. Blood Cancer"},{"key":"3001_CR292","doi-asserted-by":"publisher","first-page":"25H","DOI":"10.1016\/S0002-9149(99)00253-2","volume":"83","author":"LH Young","year":"1999","unstructured":"Young, L. H. et al. Regulation of myocardial glucose uptake and transport during ischemia and energetic stress. Am. J. Cardiol. 83, 25H\u201330H (1999).","journal-title":"Am. J. Cardiol."},{"key":"3001_CR293","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2220\/biomedres.36.225","volume":"36","author":"A Kishimoto","year":"2015","unstructured":"Kishimoto, A. et al. Immunohistochemical localization of GLUT3, MCT1, and MCT2 in the testes of mice and rats: the use of different energy sources in spermatogenesis. Biomed. Res. 36, 225\u2013234 (2015).","journal-title":"Biomed. Res."},{"key":"3001_CR294","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01549-24","volume":"69","author":"JA Watson","year":"2025","unstructured":"Watson, J. A. et al. Within-host modeling of primaquine-induced hemolysis in hemizygote glucose-6-phosphate dehydrogenase deficient healthy volunteers. Antimicrob. Agents Chemother. 69, e0154924 (2025).","journal-title":"Antimicrob. Agents Chemother."},{"key":"3001_CR295","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1002\/cpt.3333","volume":"116","author":"N Gronich","year":"2024","unstructured":"Gronich, N., Rosh, B., Stein, N. & Saliba, W. Medications and acute hemolysis in G6PD-deficient patients - a real-world study. Clin. Pharmacol. Ther. 116, 1537\u20131543 (2024).","journal-title":"Clin. Pharmacol. Ther."},{"key":"3001_CR296","doi-asserted-by":"publisher","first-page":"1393213","DOI":"10.3389\/fimmu.2024.1393213","volume":"15","author":"SS Shah","year":"2024","unstructured":"Shah, S. S., Stone, E. F., Francis, R. O. & Karafin, M. S. The global role of G6PD in infection and immunity. Front. Immunol. 15, 1393213 (2024).","journal-title":"Front. Immunol."},{"key":"3001_CR297","doi-asserted-by":"publisher","first-page":"57","DOI":"10.31083\/j.fbl2803057","volume":"28","author":"M Dahlmanns","year":"2023","unstructured":"Dahlmanns, M., Dahlmanns, J. K., Savaskan, N., Steiner, H. H. & Yakubov, E. Glial glutamate transporter-mediated plasticity: system x(c)(-)\/xCT\/SLC7A11 and EAAT1\/2 in brain diseases. Front. Biosci. 28, 57 (2023).","journal-title":"Front. Biosci."},{"key":"3001_CR298","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1038\/s41556-025-01673-2","volume":"27","author":"J Wan","year":"2025","unstructured":"Wan, J. et al. Lactate dehydrogenase B facilitates disulfidptosis and exhaustion of tumour-infiltrating CD8(+) T cells. Nat. Cell Biol. 27, 972\u2013982 (2025).","journal-title":"Nat. Cell Biol."},{"key":"3001_CR299","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1089\/ars.2011.4221","volume":"16","author":"\u00c9 Margittai","year":"2012","unstructured":"Margittai, \u00c9 et al. Production of H\u2082O\u2082 in the endoplasmic reticulum promotes in vivo disulfide bond formation. Antioxid. Redox Signal 16, 1088\u20131099 (2012).","journal-title":"Antioxid. Redox Signal"},{"key":"3001_CR300","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.7150\/ijbs.104598","volume":"21","author":"Y Yin","year":"2025","unstructured":"Yin, Y. et al. TMEM105 modulates disulfidptosis and tumor growth in pancreatic cancer via the \u03b2-catenin-c-MYC-GLUT1 axis. Int. J. Biol. Sci. 21, 1932\u20131948 (2025).","journal-title":"Int. J. Biol. Sci."},{"key":"3001_CR301","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13046-025-03295-w","volume":"44","author":"HF Yao","year":"2025","unstructured":"Yao, H. F. et al. CASC8 activates the pentose phosphate pathway to inhibit disulfidptosis in pancreatic ductal adenocarcinoma though the c-Myc-GLUT1 axis. J. Exp. Clin. Cancer Res. 44, 26 (2025).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"3001_CR302","doi-asserted-by":"publisher","first-page":"13995","DOI":"10.1007\/s00432-023-05211-1","volume":"149","author":"Y Li","year":"2023","unstructured":"Li, Y., Tang, M., Dang, W., Zhu, S. & Wang, Y. Identification of disulfidptosis-related subtypes, characterization of tumor microenvironment infiltration, and development of a prognosis model in colorectal cancer. J. Cancer Res. Clin. Oncol. 149, 13995\u201314014 (2023).","journal-title":"J. Cancer Res. Clin. Oncol."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-03001-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-03001-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-03001-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T10:02:23Z","timestamp":1788861743000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-03001-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":302,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3001"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-03001-y","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]},"assertion":[{"value":"9 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"379"}}